Identification
Personal identification
- Full name
- Bruno Sarmento
Citation names
- Sarmento, Bruno
Author identifiers
- Ciência ID
- E816-B6B0-06A5
- ORCID iD
- 0000-0001-5763-7553
- Scopus Author Id
- 14014524100
Knowledge fields
- Engineering and Technology - Industrial Biotechnology - Bioproducts Biomaterials
- Engineering and Technology - Nano-technology - Nano-materials
- Medical and Health Sciences - Medical Biotechnology - Biomaterials
- Medical and Health Sciences - Basic Medicine - Pharmacology and pharmacy
Languages
Language | Speaking | Reading | Writing | Listening | Peer-review |
---|---|---|---|---|---|
English | Intermediate (B1) | Intermediate (B1) | Intermediate (B1) | Intermediate (B1) | |
French | Intermediate (B1) | Intermediate (B1) | Intermediate (B1) | Intermediate (B1) | |
Portuguese | Advanced (C1) | Advanced (C1) | Advanced (C1) | Advanced (C1) | |
Spanish; Castilian | Intermediate (B1) | Intermediate (B1) | Intermediate (B1) | Intermediate (B1) | |
Italian | Intermediate (B1) | Intermediate (B1) | Intermediate (B1) | Intermediate (B1) |
Education
Degree | Classification | |
---|---|---|
2004/01/01 - 2007/10/18
Concluded
|
Pharmaceutical Sciences (Doutoramento)
Major in Pharmaceutical Technology
Universidade do Porto Faculdade de Farmácia, Portugal
"Improvement of Peptidic Drugs Oral Availability Througt Their Encapsulation in Polyelectrolytes Complexes - Made Nano Particles" (THESIS/DISSERTATION)
|
|
2002
Concluded
|
Ciências Farmacêuticas (Licenciatura)
Universidade do Porto Faculdade de Farmácia, Portugal
|
15 |
Affiliation
Science
Category Host institution |
Employer | |
---|---|---|
2019/03 - Current | Principal Investigator (Research) | Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal |
2016/05/01 - 2019/03/15 | Auxiliary Researcher (Research) | Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal |
2012/01/01 - 2016/04/30 | Researcher (Research) | Instituto Nacional de Engenharia Biomédica, Portugal |
2004/01/01 - 2007/10/18 | Researcher (Research) | Universidade do Porto Faculdade de Farmácia, Portugal |
2004/01/01 - 2004/12/31 | Visiting Researcher (Research) | Queen's University, Canada |
Teaching in Higher Education
Category Host institution |
Employer | |
---|---|---|
2020 - Current | Invited Associate Professor (University Teacher) | Cooperativa de Ensino Superior Politécnico e Universitário, Portugal |
2019 - Current | Invited Associate Professor (University Teacher) | Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal |
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal | ||
2021/11/01 - 2024/12/31 | Visiting Professor (University Teacher) | Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China |
2008/03/01 - 2020/12/31 | Assistant Professor (University Teacher) | Instituto Universitário de Ciências da Saúde, Portugal |
2013 - 2019 | Assistant Professor (University Teacher) | Instituto Universitário de Ciências da Saúde, Portugal |
2015/01/01 - 2017/12/31 | Visiting Professor (University Teacher) | Universidade Estadual do Oeste do Paraná, Brazil |
Positions / Appointments
Category Host institution |
Employer | |
---|---|---|
2021/07/01 - Current | Vice-President | Controlled Release Society, United States |
2020/01 - Current | Editor | Annals of the Brazilian Academy of Sciences, Brazil |
Annals of the Brazilian Academy of Sciences, Brazil | ||
2019/12 - Current | Vice-President | Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal |
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal | ||
2017 - Current | Editor - European Journal of Pharmaceutical Sciences | Elsevier BV, Netherlands |
2017 - Current | Member of Editorial Board - Journal of Controlled Release | Elsevier BV, Netherlands |
2010 - Current | Expert | Portuguese Evaluation Committed of Veterinary Drugs , Portugal |
2008 - Current | Research Associate | Inovapotek Pharmaceutical Research and Development Lda, Portugal |
2020 - 2023 | Chair of the International Chapter Committee of the Controlled Release Society | Controlled Release Society, United States |
2016 - 2018 | Coordenação ou direção de centro de investigação, departamento ou equivalente | Instituto Universitário de Ciências da Saúde, Portugal |
2013 - 2016 | Conselho científico/técnico-científico ou orgão correspondente | Instituto Universitário de Ciências da Saúde, Portugal |
2008 - 2016 | Member of Scientific Council | Instituto Universitário de Ciências da Saúde, Portugal |
2002/03/01 - 2002/12/31 | Farmacêutico | Farmácia Falcao, Portugal |
Others
Category Host institution |
Employer | |
---|---|---|
2022/05/16 - 2022/05/21 | Erasmus Teaching Mobility | Helsingin yliopisto, Finland |
2018/01 - 2022/01 | Member of the Board of the Direction of the Spanish Portuguese Local Chapter of the Controlled Release Society (SPLC-CRS) | Controlled Release Society, United States |
2018/01 - 2019/09 | Chair of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society | Controlled Release Society, United States |
2014/06/30 - 2014/07/04 | Erasmus Teaching Program | Universitat de Barcelona, Spain |
2013/06/17 - 2013/06/21 | Erasmus Teaching Program | Università degli Studi di Sassari, Italy |
2012/12/01 - 2012/12/08 | Mobility Teaching Program | Universidade Estadual de Maringá, Brazil |
2007/11/01 - 2012/10/31 | Post Doc Researcher | Universidade do Porto, Portugal |
2012/06/13 - 2012/06/16 | Erasmus Teaching Program | Università degli Studi di Pavia, Italy |
2010/06/01 - 2010/06/12 | Erasmus Teaching Program | Universitat de Barcelona, Spain |
2008/01/10 - 2010/02/26 | Post Doc Researcher | Københavns Universitet, Denmark |
2010/01/27 - 2010/02/19 | Invited Researcher | Northeastern University, United States |
2004/01/01 - 2007/10/18 | PhD Student | Universidade do Porto, Portugal |
2006/02/01 - 2006/08/18 | Visiting PhD student | Universidade de Santiago de Compostela, Spain |
2005/05/01 - 2005/06/30 | Visiting PhD Student | Københavns Universitet, Denmark |
2003/01/01 - 2003/12/31 | Associate manager | Associação Nacional das Farmácias, Portugal |
Outputs
Publications
Book |
|
Book chapter |
|
Conference abstract |
|
Conference paper |
|
Conference poster |
|
Encyclopedia entry |
|
Journal article |
|
Newsletter article |
|
Thesis / Dissertation |
|
Intellectual property
Patent |
|
Other
Other output |
|
Activities
Oral presentation
Presentation title | Event name Host (Event location) |
|
---|---|---|
2024/02/15 | Multicellular 3D models and compartmentalized perfusable platforms for preclinical development of nanomedicines | SPLC-CRS XVth Spanish-Portuguese Conference on Controlled Drug Delivery
(Lisbon, Portugal)
|
2023/11/17 | Modulation of pharmacokinetics of dual-targeting nanomedicines for brain disorders crossing the blood-brain barrier | RICIFA2023
(Argentina)
|
2023/11/16 | Challenges and innovative technologies in pharmaceuticals towards societal needs | CIFARP2023
(Brazil)
|
2023/10/27 | Innovative technologies in pharmaceutics and biopharmaceuticals – The exploitation of new routes for old drugs | X IberoAmerican Congress of Pharmaceutical Sciences
(Portugal)
|
2023/10 | Modulation of pharmacokinetics of dual-targeting nanomedicines for brain disorders crossing the blood-brain barrier | 14th CLINAM Summit
(Switzerland)
|
2023/09 | Multicellular 3D vascularized cell models in translation of nanomedicines | NanoInnovation Conference
(Italy)
|
2023 | Production and pre-clinical evaluation of immunogenic CD44 glycoconjugates: setting the molecular bases for novel multivalent anti-cancer glycovaccines | 14th International Meeting of the Portuguese Carbohydrate Group |
2022/06 | Multifunctional approaches to treat glioblastoma using bioengineering nanomedicines | 2022 Annual Meeting & International Conference of the Korean Society of Pharmaceutical Sciences and Technology
(South Korea)
|
2022 | Combining glucose-responsive nanoparticles and iPSCs differentiation: an innovative strategy to treat diabetes | XIVth Spanish-Portuguese Conference on Controlled Drug Delivery
(Spain)
|
2022 | Multifunctional approaches to treat glioblastoma using bioengineering nanomedicines | 2022 Annual Meeting & International Conference of the Korean Society of Pharmaceutical Sciences and Technology |
2022 | Multifunctional nanomedicines of chemotherapeutic and antiangiogenic effect to target glioblastoma validated in 3D tumor microtissue-forming unit and in vivo orthotopic model | COST ACTION CA 17140 – NANO2CLINIC Final Conference |
2022 | Tough drug delivery, let’s GUTting it out! | Controlled Release Society 2022 Annual Meeting |
2022 | From nanoparticle mucodiffusion to receptor-mediated transcytosis, let’s GUTting it out! (in diabetes and cancer) | Controlled Release Society UK-Ireland Local Chapters Meeting 2022 |
2022 | Innovative technologies in pharmaceutics and biopharmaceutics | Euritech 2022 |
2022 | Bioengineered 3D cell-based models in the assessment of drug permeability | SLAS Europe Conference 2022 |
2022 | Tough drug delivery, let’s GUTting it out! | Galenus International Workshop Valencia |
2022 | Multicompartment 3D cell-based bioengineered mucosal models in drug delivery | 13th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology |
2022 | 3D multicellular tumor immunospheroids for screening of nanomedicines | Controlled Release Society BeNeLux & France Local Chapters Meeting 2022 |
2022 | Functionalized nanomedicines for the oral delivery of anti-diabetic peptides | 20th International Pharmaceutical Technological Symposium, Ankara |
2022 | Surface-functionalized nanomedicines with FcRn-targeted ligands for intestinal delivery of semaglutide | 32th Annual Conference of the European Society of Biomaterials |
2022 | Unraveling the chemoimmunomodulatory effect of a brain and glioblastoma dual-targeted nanomedicine using a novel 3D tumor microtissue-forming unit | Controlled Release Society Annual Meeting & Expo |
2022 | Cleavable mucus-diffusive nanosystem for effective peptide delivery for the treatment of Inflammatory Bowel Disease | Controlled Release Society Annual Meeting & Expo, Montreal |
2022 | Exploring the MPTHub software for studying the transport of nanoparticles in native and surrogate mucus | Controlled Release Society Annual Meeting & Expo, Montreal |
2022 | Chitosan-based nanoplatforms for the no-invasive delivery of poorly-absorbed drugs | II Workshop on Chitin & Chitosan |
2022 | Nanomedicines for local and intracellular gastrointestinal tumor modulation. New diagnostic and therapeutic tools against multidrug resistant tumors | COST ACTION CA 17104 – STRATAGEM |
2022 | Old drugs in new nanomedicines for gastrointestinal tumors. Advancing cancer nanomedicine to the clinics: hypes, hopes and hurdles | COST ACTION CA 17140 – NANO2CLINIC: Cancer Nanomedicine - from the Bench to the Beside |
2022 | 3D models and preclinical development of nanomedicines. Preclinical Development of Cancer Nanomedicines: State of the Art and Future Perspectives | COST ACTION CA 17140 – NANO2CLINIC: Cancer Nanomedicine - from the Bench to the Beside |
2022 | Combining glucose-responsive nanoparticles and iPSCs differentiation: an innovative strategy to treat diabetes | XIVth Spanish-Portuguese Conference on Controlled Drug Delivery |
2021 | Surface modification of nanoparticles to allow improved oral absorption of anti-diabetic peptides via FcRn | FcRn-targeted therapies for Aitoimmune Disorders (Online= |
2021 | Bioengineered CD44v6-targeted nanomedicines for anticancer drug delivery | 25th Anniversary meeting of the CRS Germany Chapter (Online) |
2021 | No-invasive nanomedicines-driven approaches to treat diabetes with peptides | 4th NANOMED Erasmus Mundus Joint Master Degree workshop |
2021 | Biofunctional nanomedicines for colorectal cancer: From local to target delivery | 1st EUGLOH Symposium on Nanomedicines |
2021 | Innovative three-dimensional epithelium-stroma-endothelium intestinal model for reliable drug permeability outcomes | Controlled Release Society Annual Meeting |
2021 | Development of a novel three-dimensional bioengineered biorelevant in vitro intestinal model to screen paracellular permeability | |
2021 | Novel three-dimensional multilayer bioengineered in vitro model to perform reliable epithelial-endothelial permeability studies | I Congresso (Virtual) Brasileiro de Engenharia de Tecidos |
2021 | Nanomedicines for local and intracellular gastrointestinal tumour modulation | XV Congress of the Spanish Society of Pharmaceutics and Pharmaceutical Technology |
2021 | Surface modification of nanoparticles to allow improved oral absorption of anti-diabetic peptides via FcRn | FcRn-targeted therapies for Autoimmune Disorders |
2021 | Bioengineered CD44v6-targeted nanomedicines for anticancer drug delivery | 25th Anniversary meeting of the CRS Germany Chapter (Online) |
2020 | Combining mucodiffusion and epithelial transcytosis of nanoparticles to provide efficient absorption of anti-diabetic peptides | Nanomed-Argentina
(Argentina)
|
2020 | Receptor-mediated transport of functionalized mucodiffusive nanoparticles for enhancing intestinal absorption of anti-diabetic peptides, New Horizons of Nanobiological Therapeutics | The 43rd Korean Academy of Science and Technology International Symposium (Online Conference) |
2020 | Functionalized nanomedicines to oral delivery of anti-diabetic peptides | Drug Delivery and Precision Medicine, National University of Singapore (Online Conference) |
2020 | Molecular bioengineered nanomedicines for targeted delivery of peptides in modulation of diabetes | 12th European and Global Summit for Nanomedicine – CLINAM 2020 (Online Conference) |
2020 | Synthesis of biologic-responsive polymers for the manufacturing of docetaxel-loaded nanoparticles for glioblastoma chemotherapy | 1st Discoveries Forum on Regenerative and Precision Medicine |
2020 | Synthesis of biologic-responsive targeting polymeric conjugates to manufacture docetaxel-loaded nanoparticles for glioblastoma chemotherapy | XIII Spanish-Portuguese Conference on Controlled Drug Delivery |
2020 | Polymeric micelles obtained by a novel chitosan derivative as potential delivery nanosystem of hydrophobic drugs | XIII Spanish-Portuguese Conference on Controlled Drug Delivery |
2020 | Towards the synthesis of biologic-responsive targeting polymeric conjugates to manufacture docetaxel-loaded nanoparticles for glioblastoma chemotherapy | Controlled Release Society Annual Meeting - Online |
2020 | Novel three-dimensional multilayer bioengineered in vitro model to perform reliable epithelial-endothelial permeability studies | I Congresso (Virtual) Brasileiro de Engenharia de Tecidos |
2020 | Development of a novel three-dimensional bioengineered biorelevant in vitro intestinal model to screen paracellular permeability | |
2020 | Combining mucodiffusion and epithelial transcytosis of nanoparticles to provide efficient absorption of anti-diabetic peptides | Nanomed-Argentina 2020 |
2019 | Functionalized Nanomedicines for Mucosal and Cell-driven Recognition Drug Delivery | 17th International Symposium on Advances in Technology and Business Potential of New Drug Delivery Systems
(Mumbai, India)
|
2019 | Carbohydrate polymers for smart tailoring of bioactive drugs - A chitosan history | International Meeting of the Portuguese Carbohydrate Group
(Porto, Portugal)
|
2019 | New three-dimensional intestinal tissue engineering model as multifunctional platform for drug and nanoparticle absorption studies | Controlled Release Society Annual Meeting
(Valencia, Spain)
|
2019 | Enhanced anti-angiogenic effects of bevacizumab in glioblastoma treatment upon intranasal administration of PLGA nanoparticles | 46th Controlled Release Society Annual Meeting
(Valencia, Spain)
|
2019 | Improved topical delivery of ascorbic acid to human stratum corneum: assessment using imaging mass spectrometry | 46th Controlled Release Society Annual Meeting
(valencia, Spain)
|
2019 | Efficient ways to deliver drugs to pediatric CNS in the context of HIV | Pediatric HIV CNS Reservoir Workshop: Research, Evaluation, Monitoring for Viral Elimination
(Maryland, United States)
|
2019 | Enhanced anti-angiogenic effect of bevacizumab in PLGA nanoparticles on glioblastoma treatment upon intranasal administration | 6th Nano Today Conference
(Lisbon, Portugal)
|
2019 | 3D bioengineered intestine for drug screening absorption studies, Interrogations at the Biointerface | 7th Advanced Summer School
(Porto, Portugal)
|
2019 | Acetalated dextran nanoparticles combined with alginate cryogel for in situ vaccination | 3rd Symposium on Immunomodulation in Cancer and Regeneration – T cells and immunotherapies
(Porto, Portugal)
|
2019 | Oral peptide delivery – Improving bioavailability through formulations | Australian-New Zealand Controlled Release Society Joint Workshop, Dunedin
(New Zealand)
|
2019 | Functionalized nanomedicines for intestinal delivery of anti-diabetic peptides | Drug Delivery Australia 2019
(Australia)
|
2019 | Functionalized nanomedicines for the disruptive intestinal delivery of anti-diabetic peptides | 12th International Congress of Pharmaceutical Sciences (CIFARP) |
2019 | Biofunctionality and bioengineered poly(lactic-co-glycolic) acid in biomedicine | XV Brazilian Polymers Congress |
2019 | Functionalized PLGA nanomedicines for the disruptive delivery of biopharmaceutical drugs | 22th International Symposium on Microencapsulation |
2019 | Synthesis of biologic-responsive polymers for the manufacturing of docetaxel-loaded nanoparticles for glioblastoma chemotherapy | 1st Nano2Clinic COST Action CA17140 Conference |
2019 | Multifunctional stimuli-responsive pancreas mimetic | New frontiers in biofabrication: From biomolecules to tissues and organs |
2019 | 3D bioengineered small intestine for drug absorption studies | New frontiers in biofabrication: From biomolecules to tissues and organs |
2019 | Amphiphilic chitosan derivatives as potential delivery vehicle of hydrophobic anticancer drugs | New frontiers in biofabrication: From biomolecules to tissues and organs |
2018 | Oral peptide delivery – Balance between formulation, gut and intestinal mucosa | 7º Congress of Pharmaceutical Sciences of Mercosul, Cascavel, Brazil
(Brazil)
|
2018 | Oral peptide delivery – Balance between formulation, gut and intestinal mucosa | 3rd International Symposium on Bioavailability/Bioequivalenc of Oral Drug Products, Lisbon, Portugal
(Portugal)
|
2018 | Development and applications of chitosan-based functional materials: Advances at the macromolecular materials and lignocellulosic fibers group | Procceedings of the 16th Brazilian Congress of Thermal Sciences and Engineering
ABCM (Brazil)
|
2018 | History in the Making: development of multi-target-directed ligands for Alzheimer's disease that modulate oxidative stress/mitochondria quality and the cholinergic system | MuTaLig COST ACTION, Valleta, Malta
(Malta)
|
2018 | Functional nanomedicines for modulation the interaction with mucosal barriers | NanoPT2018, Lisbon, Portugal
(Portugal)
|
2017 | Biofunctional nanomedicines for efficient delivery of anticancer drugs in the gut | 11th International Congress of Pharmaceutical Sciences (CIFARP), Ribeirão Preto, Brazil
(Brazil)
|
2017 | Exploring bioengineered nanosystems for the safe delivery of biopharmaceuticals | 11th International Congress of Pharmaceutical Sciences (CIFARP)
(Brazil)
|
2017 | Advanced nanosystems for modulation the interaction with mucosal barriers | 6th International Symposium on Surface and Interface of Biomaterials, Chengdu, China
(China)
|
2017 | Chitosan-based systems in the delivery of biopharmaceuticals | 4th China International and Cross-Strain Chitin and Chitosan Symposium, Qingdao, China
(China)
|
2017 | Spermine-modified acetalated dextran nanoparticles for cancer chemoimmunotherapy | 44th Controlled Release Society Annual Meeting, Boston, USA
IEEE (United States)
|
2017 | Stability and bioactivity study of bevacizumab-loaded PLGA nanoparticles towards its controlled release | 43rd International Conference on Micro and NanoEngineering, Braga
(Portugal)
|
2017 | Nano-in-microparticles for oral delivery of GLP-1 and DPP4-inhibitor for diabetes therapy | 25th International Conference on Bioencapsulation, La Chapelle sur Erdre, France
(France)
|
2017 | Bioengineered nanomedicines for modulation of intestinal anti-diabetic peptide delivery | International Conference and Exhibition on Nanomedicine and Drug Delivery, Osaka, Japan
(Japan)
|
2017 | A new paradigm for antiangiogenic therapy through controlled release of bevacizumab | First SPLC-CRS Young Scientist Meeting, Santiago de Compostela, Spain
(Spain)
|
2017 | Nanoparticles-in-vaginal films for combined delivery of anti-HIV microbicide drugs | 10th International Conference & Exhibition on Pharmaceutics and Novel Drug Delivery Systems, London, United Kingdom
(United Kingdom)
|
2016 | Functionalized nanomedicines are revolutioning the next generation of drug delivery systems | X International Forum on Advances in Pharmaceutical Technology – CISDEM, Cascavel, Brazil
(Brazil)
|
2016 | Nanoparticles: a breakthrough in the treatment of arthritis | EULAR Annual European Congress of Rheumatology 2016, London, United Kingdom
(United Kingdom)
|
2016 | Edible films as oral delivery systems for xanthines extracted from medicinal plants: an experimental design approach | International Conference of Aromatic and Medicinal Herbs in Food, Bucharest, Romania
(Romania)
|
2016 | Hydrogels containing porphyrin-loaded nanoparticles for topical antimicrobial photodynamic therapy | The Singlet Oxygen Strategy: From Singlet Oxygen to Sustainable Oxidation, Gent, Belgiu
(Belgium)
|
2016 | Sistemas de entrega particulares para entrega dupla de GLP-1 e DPP4 inibidor para a terapia da Diabetes Mellitus Tipo 2 | 12º Congresso Português de Diabetes, Vilamoura, Portugal
(Portugal)
|
2016 | A new 3D cell-based engineered intestinal in vitro model to explore intestinal absorption at earlier stage of drug delivery | Cell Culture 2016, London, United Kingdom
(United Kingdom)
|
2016 | Nanomedicines for modulating diabetes: Nanoscale tools against macroscale disease | XI Spanish-Portuguese Conference on Controlled Release Society, Granada, Spain
(Spain)
|
2015 | Safety and toxicity concerns of orally delivered nanoparticles as drug carriers | IX International Forum on Advances in Pharmaceutical Technology – CISDEM, Santiago de Compostela, Spai
(Spain)
|
2015 | Chitosan-based systems for the delivery of biopharmaceutical drugs | 11th International Meeting of the Portuguese Carbohydrate Group/6th Iberian Carbohydrate Meeting, Viseu, Portugal
(Portugal)
|
2015 | Co-deliver of glucagon-like peptide-1 and dipeptidyl peptidase 4 inhibitor for treatment of type 2 diabetes | 27th European Conference on Biomaterials, Krakow, Poland
(Poland)
|
2015 | Coffee silverskin as new cosmetic ingredient: in vitro and in vivo evaluation | 42th Controlled Release Society Annual Meeting, Edinburg, Scotland
(United Kingdom)
|
2015 | Nanomedicines for modulating diabetes and cancer – Nanoscale tools against macroscale diseases | Advanced Summer School Interrogations at the Biointerface: The Nano/Medicine Interface, Porto, Portugal
(Portugal)
|
2015 | Chitosan-based systems for the delivery of biopharmaceutical drugs | X Encontro de Engenharia de Materiais da Universidade Presbiteriana Mackenzie, São Paulo, Brazil
(Brazil)
|
2015 | A new three-dimensional cell-based intestinal in vitro model to explore intestinal absorption | 12th SMI Annual Conference on Controlled Release, London, United Kingdom
(United Kingdom)
|
2015 | A new tri-dimensional cell-based intestinal engineering model to explore intestinal absorption at earlier stage of drug delivery | BiTERM 2015 - Indo-Australian conference on biomaterials, tissue engineering, drug delivery and regenerative medicine, Chennai,
India
(India)
|
2014 | A new three-dimensional cell-based intestinal in vitro model to explore intestinal absorption at earlier stage of drug delivery | SFNano Workshop 2014-Advanced tools and models for translation of advanced drug delivery systems, Porto, Portugal
(Portugal)
|
2014 | Synthesis and biological evaluation of photosensitizers for targeted photodynamic therapy of gastric cancer | XX Encontro galego-português de química, Porto, Portugal
(Portugal)
|
2014 | Nanotechnology and new Drug Products | VIII International Forum CISDEM, Improving the efficacy of good drugs into outstanding products in the R&D Process: Nanomedicines
for exceptional drug bioavailability and target, Itajaí, Brazil
(Brazil)
|
2014 | Chitosan-based systems for the delivery of biopharmaceutical drugs | International Society of Biomedical Polymers and Polymeric Materials Annual Meeting, Washington, US
(United States)
|
2014 | Green synthesis of silver nanoparticles using Withania somnifera extract and their incorporation into cream with antibacterial activity | 62nd International Congress and Annual Meeting of the Society for Medicinal Plant and Natural Product Research, Guimaraes,
Portugal
(Portugal)
|
2014 | Dapivirine-loaded polymeric nanoparticles for the prevention of vaginal HIV transmission | 9th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
(Portugal)
|
2014 | Nanoparticles for intestinal controlled release for drugs with poor solubility and poor permeability | 11th SMI Annual Conference on Controlled Release, London, United Kingdom
(United Kingdom)
|
2014 | Development of nanoparticle formulations for drug modified release in veterinary medicine | Veterinary Medicine: From vision to product, Informa LifeSciences, Berlin, Germany
(Germany)
|
2013 | Bionanotechnology applied to Pharmaceutical Sciences | 5º Congresso de Ciências Farmacêuticas do Mercosul, Cascavel, Brazil
(Brazil)
|
2013 | Determination of equilibrium solubility (ES) and partition coefficient (Kp) by high-throughput assay for the drugs dapsone and clofazimine | XIX Encontro galego-português de química, Vigo, Spain
(Spain)
|
2013 | Desenvolvimento e caracterização da daptomicina em nanopartículas lipídicas sólidas | XIX Encontro galego-português de química, Vigo, Spain
(Spain)
|
2013 | Critical factors in translational development for nanomedicines | NanoFar Autumn School 2013, Santiago de Compostela, Spain
(Spain)
|
2013 | Understanding the use of nanoparticles for modified release drug delivery for compounds with poor solubility and poor permeability | Modified Release in Oral Drug Delivery, Informa LifeSciences, Berlin, Germany
(Germany)
|
2013 | Incorporação de polifenóis em matrizes lácteas por nanoencapsulação | Instituto Politénico de Bragança, Bragança, Portugal
(Portugal)
|
2013 | Effect of a chitosan enriched biofertilizer on induced resistances against the pinewood nematode, Bursaphelenchus xylophilus | 11th International Conference of the European Chitin Society, Porto, Portugal
(Portugal)
|
2013 | Nanomedicines based on carboxymethyl chitosan for cancer and inflammation | 11th International Conference of the European Chitin Society, Porto, Portugal
(Portugal)
|
2012 | Chitosan-based systems for the delivery of biopharmaceutical drugs | 6th Iberoamerican Chitin Symposium / 12th International Conference on Chitin and Chitosan, Fortaleza, Brazil
(Brazil)
|
2012 | Locust Bean Gum based nanoparticulate system for oral antigen delivery | 9th Central European Symposium on Pharmaceutical Technology, Dubrovnik, Croatia
(Croatia)
|
2012 | Challenges in formulation and delivery of biopharmaceutical drugs | ShareBiotech Second Transnational Event, Pamplona, Spain
(Spain)
|
2012 | Chitosan-coated solid lipid nanoparticles for the oral absorption enhancement of insulin | 2nd World Congress on Pharmaceutics & Novel Drug Delivery Systems, San Francisco, USA
(United States)
|
2012 | Pharmacokinetic-pharmacodynamic model for dosification of carboplatin-gemcitabine scheme in elderly advanced non-small cell lung cancer patients – Analytical phase | XLII Reunião Anual da Sociedade Portuguesa de Farmacologia, Lisbon, Portugal
(Portugal)
|
2011 | Challenges in formulation and delivery of biopharmaceutical drugs | 1º Curso de la “Red Iberoamericana de Nuevos Materiales para el Diseño de Sistemas Avanzados de Liberación de Fármacos en
Enfermedades de Alto Impacto Socioeconómico (RIMADEL)”, Santiago de Compostela, Spain
(Spain)
|
2011 | Establishment of a new in vitro triple intestinal co-culture cell model to evaluate and correlate in vivo intestinal absorption of nanoparticles and therapeutic proteins | IX Spanish-Portuguese Conference on Controlled Drug Delivery, Porto, Portugal
(Portugal)
|
2011 | Oral absorption enhancement of insulin-loaded chitosan-coated solid lipid nanoparticles | XIX International Workshop on Bioencapsulation, Amboise, France
(France)
|
2010 | Novel locust bean gum nanoparticles for protein delivery | XVIII International Conference on Bioencapsulation, Porto, Portugal
(Portugal)
|
2010 | From science to practice: Eliminating the border | 70th FIP International Congress, Lisbon, Portugal
(Portugal)
|
2010 | Chitosan nanoparticles for the encapsulation of drugs: Potential applications in tuberculosis | I Latin American Symposium of Nanomedicines, La Plata, Argentina
(Argentina)
|
2010 | Bioactive xanthones: prediction of intestinal absorption and effects on P-glycoprotein activity | XVI Encontro Luso-Galego de Química, Aveiro, Portugal
(Portugal)
|
2010 | Avaliação da actividade antioxidante, antimicrobiana e apoptótica do óleo essencial de Zanthoxylum tingoassuiba em lipossomas | XVIII Congresso Brasileiro de Engenharia Química, Foz do Iguaçu, Brasil
(Brazil)
|
2010 | Chitosan-cetuximab conjugate for pulmonary paclitaxel delivery – preliminary concepts | 8th International Symposium on Polymer Therapeutics: Laboratory to Clinical Practice, Valência, Spain
(Spain)
|
2010 | Prediction of intestinal absorption of bioactive xanthones across Caco-2 cell monolayers using an HPLC-UV method | Third Meeting of Young Researchers of University of Porto, Porto, Portugal
(Portugal)
|
2009 | Therapeutic polymers and cancer treatment | Neoplasia Workshop, Gandra, Portugal
(Portugal)
|
2009 | Antimicrobial activity of Zanthoxylum tingoassoiba essential oil entrapped in liposomes and chitosan particles | Second Meeting of Young Researchers of University of Porto, Porto, Portugal
(Portugal)
|
2008 | Chitosan-stealth polymeric nanoparticles for mucosal insulin delivery | Ehrlich II – 2nd World Conference on Magic Bullets, Nuremberg, Germany
(Germany)
|
2008 | Improvement of insulin oral availability through encapsulation in polyelectrolyte complexes | 7th Conference and Workshop on Biological Barriers and Nanomedicine – Advanced Drug Delivery and Predictive non vivo Testing
Technologies, Saarbrucken, Germany
(Germany)
|
2008 | Liposome-incorporated Zanthoxylum tingoassuiba essential oil: preparation and characterization | First Meeting of Young Researchers of University of Porto, Porto, Portugal
(Portugal)
|
2007 | Oral delivery of insulin by new polysaccharide nanoparticles | 3th Pharmaceutical Sciences World Congress (PSWC2007), Amsterdam, Netherlands
(Netherlands)
|
2006 | New alginate/chitosan nanoparticles for oral delivery of insulin | VII Spanish-Portuguese Conference on Controlled Drug Delivery, Pamplona, Spain
(Spain)
|
Supervision
Thesis Title Role |
Degree Subject (Type) Institution / Organization |
|
---|---|---|
2022/08 - Current | Engineering a 3D cell-laden dynamic model of human liver fibrosis to evaluate antifibrotic nano-based drug delivery systems
Supervisor
|
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2022/08 - Current | InSyCOBets: Insulin-producing synthetic cells as bioengineering oral delivery systems to treat diabetes
Supervisor
|
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2022 - Current | Development of a Novel Combination Therapy for Colorectal Cancer based on CD44v6-Targeted Chemotherapy with Immunotherapy
Supervisor
|
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2021 - Current | 3D-CRCol: 3D organotypic ColoRectal cancer spheroid model with healthy colon for drug and nanoparticle safety and efficacy
screening
Supervisor
|
|
2013 - Current | Combination antiretroviral drug/siRNA-loaded targeted nanocarriers for preventing vaginal HIV transmission
Supervisor
|
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2023/01 - 2026/12 | Development of a novel nanoparticle system for combined photodynamic and immunotherapy of lung cancer characterized in a 3D
model by metabolic imaging
Supervisor
|
PhD (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2022/01 - 2026/04 | Establishing a novel nanoparticle-based system for immuno-chemotherapy delivery in rectal cancer
Supervisor
|
Instituto Universitário de Ciências da Saúde, Portugal
|
2022 - 2025/03 | NanoBlast: an innovative cancer vaccine for in situ glioblastoma chemoimmunotherapy
Supervisor
|
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2022/08 - 2025 | HI-FORCE - Engineering Hybrid Exosomes For Breast Cancer Vaccine
Co-supervisor
|
|
2020/09 - 2024/10 | Engineering anisotropic nanoparticles as super-diffusive carriers for oral administration of therapeutic peptides
Co-supervisor
|
Biomedical Sciences (PhD)
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2020 - 2024/10 | Co-targeting of glycolytic cancer metabolism and angiogenesis through polymeric nanoparticles for glioblastoma therapeutics
Supervisor
|
Biological Sciences Applied to Health (PhD)
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal |
2020/01/01 - 2024/02/01 | Nanoenabled 3D Bioprinted Microtissue with Immunomodulatory Properties for Cartilage Repair
Co-supervisor
|
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2023/12 - 2024/02 | Avaliação da atividade anti-inflamatória de nanopartículas mucoadesivas de alginato de sódio e quitosana contendo mesalazina
em modelo 3D de inflamação intestinal multicamadas
Co-supervisor
|
PhD (PhD)
Universidade Estadual Paulista Júlio de Mesquita Filho, Brazil
|
2022/08 - 2024/02 | A second opportunity to second-generation antimitotics for the treatment of lung cancer
Co-supervisor
|
Instituto Universitário de Ciências da Saúde, Portugal
|
2020 - 2024/02 | Cleavable mucus-penetrating nanosystems for effective intestinal peptide delivery in the treatment of inflammatory bowel disease
Supervisor
|
Biomedical Sciences (PhD)
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2020 - 2024/02 | Combined human exposure to fish and seafood contaminant mixtures: bio-accessibility, assimilation efficiency and toxicity
Co-supervisor
|
BioSciences (PhD)
Universidade de Aveiro, Portugal
|
2019 - 2024/02 | Oral delivery of semaglutide through multifunctional FcRn-peptide targeting nanoparticles for treatment of type 2 diabetes
mellitus
Supervisor
|
Biomedical Sciences (PhD)
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2019 - 2024/02 | Development of targeted nanomedicines for the stabilization and repair of central nervous system myelin under assault by acquired
demyelinating diseases
Supervisor
|
Biomedical Sciences (PhD)
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2020 - 2023/12 | Development of a resveratrol solid dispersion with enhanced oral bioavailability by the lyophilization method
Supervisor
|
Biomedical sciences (PhD)
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2019 - 2023/10 | Nanomedicine as a tool to surpass bioavailability constraints: development of polymeric nanoparticles smart carriers for single
or combined drug delivery
Co-supervisor
|
Pharmaceutical Sciences (PhD)
Universidade do Porto Faculdade de Farmácia, Portugal
|
2018 - 2023/05 | Multi-targeted docetaxel polymeric nanoparticles as delivery systems for chemotherapy to treat glioblastoma
Supervisor of Claudia Freitas Martins
|
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal |
2022/02 - 2023/04 | Synthesis of Rf@N,S-GQD@AuNSs for Two-photon PDT and PTT by pulse laser irradiation
Co-supervisor
|
|
2022 - 2023/02 | Neonatal Fc receptor-mediated intestinal transport of functionalized nanoparticles with semaglutide for type 2 diabetes
Supervisor
|
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2020 - 2023 | glycoINSPIRER: A multivalente glycocode-inpired nanovaccine for bladder cancer immunotherapy
Co-supervisor
|
Biomedical Sciences (PhD)
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2019 - 2023 | Immunomodulatory functionalized CEA-targeted nanoparticles to improve chemotherapeutic treatment in metastatic colorectal
cancer
Supervisor
|
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2019 - 2023 | Multistage pancreas biomimetic construct based on synergism of functionalized nanomedicines and cell differentiation
Supervisor
|
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2019 - 2023 | Multifunctional natural derived peptide extracts for skin care
Co-supervisor
|
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2019 - 2023 | Construction of a multivalent glycan-based nanovaccine for bladder cancer: A step towards effective immunotherapies
Co-supervisor
|
|
2018 - 2023 | Targeted cathelicidin nanomedicines as novel glucoregulator for diabetes therapy
Supervisor
|
|
2018 - 2023 | Antifungal peptide-loaded nanoparticles-in-films for the management of vulvovaginal candidiasis
Co-supervisor
|
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal |
2018 - 2023 | Innovative nanoparticles for targeted therapy delivery in gastrointestinal cancer
Co-supervisor
|
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal |
2017 - 2023 | Immunonanoparticles as target delivery platforms of photosensitizers for colorectal cancer photodynamic therapy
Co-supervisor
|
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal |
2021/09 - 2022 | Desenvolvimento e caracterização de nanoformulação contendo furoato de mometasona para administração oral
Co-supervisor
|
|
2021/04 - 2022 | Explore peptide-based screening towards neonatal Fc receptor-mediated mucosal transport for functionalize nanoparticles loading
anti-diabetic peptides
Supervisor
|
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2021/01 - 2022 | Establishment of a 3D multi-layered intestinal inflammation model
Supervisor
|
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2019 - 2022 | Vaginal rings for sustained release of nanoparticles containing antimicrobial peptides: A new strategy for managing recurrent
vulvovaginal candidiasis
Co-supervisor
|
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2018 - 2022 | Graphene Quantum Dots for cancer theranostic
Co-supervisor
|
Universidade do Minho Escola de Ciências, Portugal
|
2018 - 2022 | Azurin peptide-decorated gefitinib-loaded nanoparticles: development, characterization and in vitro evaluation of their anti-lung
cancer activity
Co-supervisor
|
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Universidade de Lisboa, Portugal |
2017 - 2022 | New three-dimensional intestinal tissue engineering model as multifunctional platform for drug and nanoparticle absorption
studies
Supervisor
|
|
2016 - 2022 | Therapeutic targeting of cell division through functionalized nanoparticle-mediated siRNA delivery for the treatment of lung
cancer
Co-supervisor
|
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
|
2015 - 2022 | Unraveling the role of the microenvironment and molecular mechanisms of resistance in tumor cells
Co-supervisor
|
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
|
2020 - 2021 | Development of a bioengineered pancreas using iPSCs to treat type 1 diabetes
Supervisor
|
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2016 - 2021 | Mucoadhesive camptothecin polymeric micelles as nanodelivery systems for oral chemotherapy to treat colorectal cancer
Supervisor
|
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal |
2016 - 2021 | New engineered FcRn-targeting nanoplatfoms for oral delivery of biopharmaceuticals
Supervisor
|
|
2019 - 2020 | RESTORE- User-centred smart nanobiomaterial-based 3D matrices for chondral repair
Supervisor
|
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2018 - 2020 | Multifunctional nanomedicine for intracelular delivery of antibody to CD44v6 expressing cancer cells
Supervisor
|
Universidade de Aveiro, Portugal
|
2015 - 2020 | Theranostic nanocomposites for simultaneous cancer immunotherapy and imaging controlled release
Supervisor
|
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2015 - 2020 | Bioengineered-ligand functionalization of nanoparticles towards systemic delivery of biopharmaceuticals through intestinal
FcRn-mediated transcytosis
Co-supervisor
|
|
2014 - 2020 | Development of a resveratrol drug delivery system presenting enhanced bioavailability
Supervisor
|
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal Bial, Portugal |
2019/01 - 2019/09 | Chemo-immunomodulatory nanoparticles for colorectal cancer in a spheroid-based model
Supervisor
|
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2015 - 2019/04/05 | Study of biophysical interactions and antibody bioactivity of bevacizumab encapsulated into nanoparticles towards its controlled
release
Supervisor
|
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2018 - 2019 | Structured Programme on Bioengineering Therapies for Infectious Diseases and Tissue Regeneration
Supervisor
|
|
2018 - 2019 | Desenvolvimento e avaliação farmacocinética de formulação inalatória de clofazimina modificada como alternativa ao tratamento
de tuberculose resistente a múltiplos fármacos
Co-supervisor
|
Universidade Federal do Rio de Janeiro Faculdade de Farmácia, Brazil
|
2018 - 2019 | Development, characterization and safety evaluation for topical application of nanostructured lipid carriers containing protocatechuic
acid and ethyl protocatechuate
Co-supervisor
|
Universidade Estadual de Maringá Centro de Ciências da Saúde, Brazil
|
2018 - 2019 | Characterization of nutritional and healthy properties of local Tuscany varieties and evaluation of innovative nanosystems
for the delivery of their nutraceutical components to the human body
Co-supervisor
|
Università degli Studi di Siena Biblioteca Centrale Facolta di Farmacia, Italy
|
2018 - 2019 | Establishment of bioengineered glucose-responsive nanoparticles for type 2 diabetes mellitus therapy
Supervisor
|
Universidade Nova de Lisboa, Portugal
|
2018 - 2019 | NETDIAMOND - Novos alvos na insuficiência cardíaca diastólica: das comorbilidades à medicina personalizada
Supervisor
|
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2018 - 2019 | Development of oral strips containing nanoencapsulated bioactive compounds
Supervisor
|
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2016 - 2019 | Targeting colorectal cancer and cancer stem cells with innovative bioengineered drug delivery systems
Supervisor
|
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Vall d'Hebron Institut de Recerca, Spain |
2016 - 2019 | Optimization of lyophilization parameters of polymeric nanoparticles for delivery therapeutic proteins
Supervisor
|
Universidade do Porto Faculdade de Farmácia, Portugal
|
2016 - 2019 | Combination antiretroviral drug/siRNA-loaded targeted nanocarriers for preventing vaginal HIV transmission
Supervisor
|
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2014 - 2019 | Tissue engineered 3D models of gastric wall for permeability studies of drug-loaded nanoparticles
Co-supervisor
|
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2018/01 - 2018/12 | Structured Programme on Bioengineering Therapies for Infectious Diseases and Tissue Regeneration
Supervisor
|
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2018 - 2018 | Development of nanocarriers for anti-CCR5 siRNA and their potential as microbicide candidates
Co-supervisor
|
Universidade do Porto Faculdade de Engenharia, Portugal
|
2018 - 2018 | Development and characterization of protein-based nanoparticles containing ferulic acid
Co-supervisor
|
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
Universidade Estadual do Centro-Oeste, Brazil |
2018 - 2018 | Targeting potential metastatic early-stage CRC with PLGA nanoparticles carrying siRNA MACC1
Supervisor
|
Universidade do Porto, Portugal
|
2018 - 2018 | Development of Nanoparticle-in-Microparticle systems for oral delivery of triptorelin
Supervisor
|
Universidade do Porto, Portugal
|
2018 - 2018 | Establishment of a biomimetic epithelium-stroma-endothelium 3D tissue engineering interface to screen intestine drug permeation
Supervisor
|
University of Glasgow School of Life Sciences, United Kingdom
|
2018 - 2018 | Engineered siRNA-loaded nanocarriers for CCR5 targeting and silencing
Co-supervisor
|
Universidade do Porto, Portugal
|
2017 - 2018 | Nanotherapies involving nanoparticles in the treatment of colorectal cancer
Supervisor
|
Universidade do Porto, Portugal
|
2017 - 2018 | Development of polymeric nanoparticles of saquinavir targeting SNC through microfluidic platforms
Supervisor
|
Universidade do Porto Faculdade de Engenharia, Portugal
Instituto Nacional de Engenharia Biomédica, Portugal |
2017 - 2018 | Nanoparticle-in-thermosensitive enemas as novel rectal anti-HIV microbicides
Co-supervisor
|
Engenharia Biomédica (Master)
Universidade de Coimbra, Portugal
|
2017 - 2018 | Vaginal Tenofovir/Emtricitabine-loaded nanoparticles in films as an alternative to oral PrEP
Co-supervisor
|
Bioquímica Aplicada (Master)
Universidade do Minho, Portugal
|
2017 - 2018 | Nanoparticle-based strategies for the delivery of antiretroviral compounds to HIV-susceptible cells
Co-supervisor
|
Bioengenharia (Master)
Universidade do Porto, Portugal
|
2017 - 2018 | Estudos in vitro de permeabilidade intestinal de nanopartículas poliméricas mucoadesivas contendo metotrexato em modelo de
co-cultura tripla de células
Co-supervisor
|
Universidade Estadual Paulista Júlio de Mesquita Filho - Câmpus de Araraquara, Brazil
|
2017 - 2018 | New three-dimensional intestinal tissue engineering model as multifunctional |
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2017 - 2018 | Cell penetrating p28 peptide-mediated delivery of nanomedicines for cancer treatment
Supervisor
|
Junior Researcher (Other)
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2014 - 2018 | Glycan-based nanotherapeutics for selective drug delivery in gastric cancer
Co-supervisor
|
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal Instituto Português de Oncologia de Lisboa Francisco Gentil EPE, Portugal |
2014 - 2018 | Development of a dual-drug delivery system with the complement of biophysical studies of drug-membrane interaction to improve
the current therapy against Helicobacter pylori
Co-supervisor
|
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2013 - 2018 | Nanotechnology-based strategies for rectal anti-HIV pre-exposure prophylaxis
Supervisor
|
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
Instituto Nacional de Engenharia Biomédica, Portugal |
2013 - 2018 | Innovative colorectal cancer diagnosis and treatment with engineered nanoparticles
Supervisor
|
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
Instituto Nacional de Engenharia Biomédica, Portugal |
2013 - 2018 | The use of three-dimensional cell culture tissue models of the pulmonary epithelium for an in vitro/in vivo comparison of
pulmonary toxicity of nanocarriers
Co-supervisor
|
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
Instituto Nacional de Engenharia Biomédica, Portugal Cooperativa de Ensino Superior Politécnico e Universitário, Portugal |
2017 - 2017 | New Oral Nanomedicines: Transporting Therapeutic Macromolecules across the Intestinal barrier
Co-supervisor
|
Instituto Nacional de Engenharia Biomédica, Portugal
|
2016 - 2017 | Systemic delivery of an orally-administered biopharmaceutical by surface functionalization of polymeric nanoparticles exploiting
intestinal neonatal Fc receptor
Supervisor
|
Hochschule Kaiserslautern, Germany
|
2016 - 2017 | Development and characterization of blends of synthetic polymers and polysaccharides for controlled drug delivery of drugs
Co-supervisor
|
Universidade Estadual do Oeste do Paraná, Brazil
|
2016 - 2017 | Production and characterization of NLCs for insulin delivery
Supervisor
|
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
|
2012 - 2017 | Quality by Design application during the development of solid dispersions drugs to treat leprosy
Co-supervisor
|
Universidade do Porto Faculdade de Farmácia, Portugal
|
2016 - 2016 | Evaluate the ability of the nanoparticles to cross the blood brain barrier using an in vitro model and different functionalization
of surface of nanoparticles
Co-supervisor
|
Instituto Nacional de Engenharia Biomédica, Portugal
Universidad de Sevilla Facultad de Farmacia, Spain |
2016 - 2016 | Implementation of a microfluidic flow focusing device for the development of drug encapsulated PLGA nanoparticles by nanoprecipitation
Supervisor
|
Instituto Nacional de Engenharia Biomédica, Portugal
|
2015 - 2016 | Development of polycaprolactone-grafted chitosan polymers for mucoadhesive nanodelivery systems
Supervisor
|
Universidade do Porto Faculdade de Engenharia, Portugal
Instituto Nacional de Engenharia Biomédica, Portugal |
2015 - 2016 | Establishment and optimization of an alginate-anchored tridimensional in vitro intestine model for intestinal absorption purposes
Supervisor
|
Universidade do Porto Faculdade de Engenharia, Portugal
Instituto Nacional de Engenharia Biomédica, Portugal |
2015 - 2016 | Development and characterization of a co-culture two-dimensional blood brain barrier for study nanoparticle permeation
Supervisor
|
Universidade do Porto Faculdade de Engenharia, Portugal
Instituto Nacional de Engenharia Biomédica, Portugal |
2015 - 2016 | Development and optimization of a methodology to synthetize chitosan/Cetuximab conjugates for encapsulate siRNA and targeting
to EGFR overexpressing cells
Co-supervisor
|
Terapias Moleculares (Master)
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
|
2015 - 2016 | Complex cell-based model of intestine permeability
Co-supervisor
|
Bioengenharia (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2012 - 2016 | Modulation of drug efflux at the blood-brain barrier through targeted siRNA delivery via nanoparticles
Supervisor
|
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
Instituto Nacional de Engenharia Biomédica, Portugal |
2011 - 2016 | In vitro/in vivo correlation of peguilated lipid nanoparticles for intravenous administration of daptomycin
Co-supervisor
|
Universidade do Porto Faculdade de Farmácia, Portugal
|
2010 - 2016 | New derivatives of Locust Bean Gum for application in nanoparticle drug delivery systems
Supervisor
|
Universidade do Porto Faculdade de Farmácia, Portugal
|
2010 - 2016 | Innovative functional polymer therapeutic nanotechnologies for siRNA delivery in lung cancer
Supervisor
|
Universidade do Porto Faculdade de Farmácia, Portugal
Northeastern University College of Life Sciences and Health, China |
2015 - 2015 | Micro e nanoparticulas de goma gelano/pectina para o aumento da biodisponibilidade oral do resveratrol
Co-supervisor
|
Universidade Estadual Paulista Júlio de Mesquita Filho - Câmpus de Araraquara, Brazil
|
2015 - 2015 | Amphiphilic derivatives of chitosan in encapsulation and controlled release of antitumor drugs
Co-supervisor
|
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
Universidade de São Paulo Instituto de Química de São Carlos, Brazil |
2015 - 2015 | Development and characterization of polymeric vaginal films containing nanoparticles
Supervisor
|
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
|
2014 - 2015 | Combined human exposure to fish and seafood contaminant mixtures: bio-accessibility, assimilation efficiency and toxicity
Supervisor
|
Universidade de Aveiro, Portugal
|
2014 - 2015 | Development and characterization of three-dimensional intestinal model for studying intestinal nanoparticle absorption
Supervisor
|
Universidade do Porto Faculdade de Engenharia, Portugal
Instituto Nacional de Engenharia Biomédica, Portugal |
2014 - 2015 | Multifunctional solid lipid nanoparticles for theranostics application in rheumatoid arthritis
Supervisor
|
Universidade do Porto Faculdade de Engenharia, Portugal
Instituto Nacional de Engenharia Biomédica, Portugal |
2014 - 2015 | Mucoadhesive alginate-based nanoparticles for daptomycin delivery in ocular treatment of bacterial endophthalmitis
Co-supervisor
|
Universidade Católica Portuguesa Centro Regional do Porto, Portugal
|
2014 - 2015 | Permeation study of vaginal clotrimazole by the method of Ussing chamber
Co-supervisor
|
Universidade da Beira Interior Faculdade de Ciências da Saúde, Portugal
|
2014 - 2015 | Study of ex vivo vaginal clindamycin permeation using Ussing chambers
Supervisor
|
Universidade da Beira Interior Faculdade de Ciências da Saúde, Portugal
|
2010 - 2015 | Glucose-sensitive nanocarriers for controlled pulmonary administration of insulin
Supervisor
|
Universidade do Porto Faculdade de Farmácia, Portugal
|
2010 - 2015 | Study of the neuroprotective potential of extracts and/or compounds of Crataegus oxyacantha and development of nanoparticles
containing with neuroprotective properties
Co-supervisor
|
Universidade do Minho, Portugal
|
2010 - 2015 | Development of nanoparticles containing extracts and/or compounds of medicinal plants (Curcuma longa, Hypericum perforatum
and Withania somniphera) with neuroprotective properties
Co-supervisor
|
Universidade do Minho, Portugal
|
2014 - 2014 | Development of oral strips containing nanoencapsulated bioactive compounds
Supervisor
|
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2014 - 2014 | Development of controlled release formulation of high permeability drugs in colon
Co-supervisor
|
Instituto Nacional de Engenharia Biomédica, Portugal
|
2014 - 2014 | Development of oral strips containing nanoencapsulated bioactive compounds
Supervisor
|
Instituto Nacional de Engenharia Biomédica, Portugal
|
2014 - 2014 | Instituto de Bioengenieria en Red para el Envejecimento Saludable
Supervisor
|
Instituto Nacional de Engenharia Biomédica, Portugal
|
2014 - 2014 | Development of oral strips containing nanoencapsulated bioactive compounds
Supervisor
|
Instituto Nacional de Engenharia Biomédica, Portugal
|
2014 - 2014 | Effect of bioprinting parameters on the biological behavior of cells printed within biofunctional hydrogels
Supervisor
|
Instituto Nacional de Engenharia Biomédica, Portugal
Università degli Studi di Parma Dipartimento di Bioscienze, Italy |
2014 - 2014 | Development of oral strips containing nanoencapsulated bioactive compounds
Supervisor
|
Instituto Nacional de Engenharia Biomédica, Portugal
|
2014 - 2014 | Development and characterization of polymeric vaginal films
Supervisor
|
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
|
2013 - 2014 | Development of multifunctional nanoparticles for targeted therapy and imaging of rheumatoid arthritis
Supervisor
|
Universidade do Porto Faculdade de Engenharia, Portugal
Instituto Nacional de Engenharia Biomédica, Portugal |
2013 - 2014 | Study of ex vivo vaginal clindamycin permeation using Ussing chambers
Co-supervisor
|
Universidade Católica Portuguesa Centro Regional do Porto, Portugal
|
2013 - 2014 | Mucoadhesive chitosan nanoparticles for daptomycin delivery in ocular treatment of bacterial endophthalmitis - Development,
characterization and in vitro evaluation.
Co-supervisor
|
Universidade Católica Portuguesa Centro Regional do Porto, Portugal
|
2013 - 2014 | Targeting siRNA to lung cancer treatment through EGFR antibody decorated nanoparticles
Co-supervisor
|
Universidade de Aveiro, Portugal
|
2012 - 2014 | Photodynamic therapy of stomach cancer: synthesis and biological evaluation of third generation photosensitizers
Co-supervisor
|
Universidade de Aveiro, Portugal
|
2011 - 2014 | Development of combination antiretroviral-loaded nanoparticles-in-vaginal film
Supervisor
|
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
|
2009 - 2014 | Chitosan-based nanomedicine for rosmarinic acid ocular delivery
Supervisor
|
Universidade do Porto Faculdade de Farmácia, Portugal
Universidade Católica Portuguesa Instituto de Ciências da Saúde Porto, Portugal |
2013 - 2013 | Nanopartículas termo-responsivas de goma do cajueiro como veículo de libertação de fármacos anticancerígenos
Co-supervisor
|
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
|
2013 - 2013 | Understanding the mechanisms of protein intestinal permeation by using enterocytes-based in vitro co-culture cells
Supervisor
|
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
|
2013 - 2013 | Validation of in vitro co-culture cell-based intestinal models for drug permeability screening
Supervisor
|
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
|
2012 - 2013 | O2 in target-specific medicinal applications
Supervisor
|
Inovapotek Pharmaceutical Research and Development Lda, Portugal
|
2012 - 2013 | GLP-1 and GLP-1 analogs nanotechnology-based systems for prevention and therapy of diabetes
Supervisor
|
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
Instituto Nacional de Engenharia Biomédica, Portugal |
2012 - 2013 | Nanotransportadores para Administração Pulmonar de Proteínas Terapêuticas
Supervisor
|
Universidade do Porto Faculdade de Farmácia, Portugal
|
2012 - 2013 | A Process Analytical Technology Approach based on Spectroscopy Techniques and Multivariate Data Analysis: Quantifying Ternary
Mixtures of Amlodipine Besylate Solid Forms
Co-supervisor
|
Universidade do Porto Faculdade de Farmácia, Portugal
|
2012 - 2013 | Optimização da estabilidade de formulações cosméticas conendo filtros solares e vitaminas pelo uso de benzotriazolil dodecil
p-cresol
Co-supervisor
|
Universidade do Porto, Portugal
|
2012 - 2013 | Microencapsulação de células com fins terapêuticos
Co-supervisor
|
Universidade do Porto, Portugal
|
2008 - 2013 | Association of micro and nanocarriers with thin films aiming higher biopotency through buccal delivery
Co-supervisor
|
Universidade Católica Portuguesa Escola Superior de Biotecnologia, Portugal
|
2008 - 2013 | Polymeric nanoparticles as carrier systems for antiretroviral agents to be used in the prevention of vaginal HIV transmission
Co-supervisor
|
Universidade do Porto Faculdade de Farmácia, Portugal
Northeastern University College of Life Sciences and Health, China |
2012 - 2012 | Encapsulation and delivery of siRNA into solid lipid nanoparticles for brain delivery through oral route – PhD Thesis
Co-supervisor
|
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
|
2012 - 2012 | Evaluation of calcitonin stability entrapped into solid lipid nanoparticles through FTIR spectroscopy
Supervisor
|
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
|
2008 - 2012 | Caracterização física e química de microcápsulas de bioaroma de queijo produzidas por atomização
Co-supervisor
|
Universidade Federal de Lavras, Brazil
|
2011 - 2011 | Evaluation of calcitonin structural stability after encapsulation into polymeric nanoparticles by SDS-PAGE
Supervisor
|
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
|
2011 - 2011 | Development of combination antiretroviral-loaded nanoparticles-in-vaginal film systems for preventing HIV transmission
Supervisor
|
Instituto Nacional de Engenharia Biomédica, Portugal
|
2011 - 2011 | Encapsulation of insulin into chitosan-coated solid lipid nanoparticles
Supervisor
|
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
|
2010 - 2011 | Valuation of stability and toxicity of nanoparticles as delivery systems of bioactive substances in dairy products
Co-supervisor
|
Universidade Católica Portuguesa Instituto de Ciências da Saúde Porto, Portugal
|
2010 - 2010 | Therapeutic conjugate polymer targeted as specific delivery of gene-based anticancer agents for non-small lung cancer
Supervisor
|
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
|
2010 - 2010 | Therapeutic conjugate polymer targeted as specific delivery of gene-based anticancer agents for non-small lung cancer
Supervisor
|
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
|
2009 - 2010 | Preparation of core-shell particulate delivery systems using supercritical fluid technology: Application to oral delivery
of proteins
Co-supervisor
|
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal
|
2009 - 2009 | In vitro methodologies for the evaluation of drug’s permeation using cell co-cultures as a tool for biosimilars control
Supervisor
|
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
|
2009 - 2009 | Strategies to overcome mononuclear phagocyte system phagocytosis of nanoparticles containing therapeutic proteins
Supervisor
|
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
|
2009 - 2009 | Formulation approaches for overcoming therapeutic proteins instability assessed by Fourier Transform Infrared spectroscopy
Supervisor
|
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
|
2009 - 2009 | Formulation approaches for overcoming therapeutic proteins instability assessed by Fourier Transform Infrared spectroscopy
Supervisor
|
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
|
2008 - 2008 | Freeze-drying approaches for overcoming instability of therapeutic proteins encapsulated into nanoparticles
Supervisor
|
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
|
2008 - 2008 | Freeze-drying approaches for overcoming instability of therapeutic proteins encapsulated into nanoparticles
Supervisor
|
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
|
2008 - 2008 | Lipid and Chitosan Particles Entrapping Essential Oil for Pharmaceutical and Medical Applications
Supervisor
|
Universidade do Porto Faculdade de Farmácia, Portugal
|
2008 - 2008 | Aplicação de métodos de produção de nanotecnologias de PLGA no fabrico de medicamentos
Supervisor
|
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
|
2008 - 2008 | Ussing system as advanced tool for study mucosal absorption of drugs
Supervisor
|
Universidade do Porto Faculdade de Farmácia, Portugal
|
2008 - 2008 | Potential of PLGA nanoparticles coated with chitosan as carriers for oral insulin delivery
Supervisor
|
Universidade do Porto Faculdade de Farmácia, Portugal
|
2008 - 2008 | Caco-2 based co-culture cells for determine insulin-loaded solid lipid nanoparticles intestinal absorption
Supervisor
|
Universidade do Porto Faculdade de Farmácia, Portugal
|
2007 - 2007 | Chitosan particles as new essential oil carrier for antimicrobial application
Supervisor
|
Universidade do Porto Faculdade de Farmácia, Portugal
|
2007 - 2007 | Liposome-incorporated Zanthoxylum tingoassuiba essential oil
Supervisor
|
Universidade do Porto Faculdade de Farmácia, Portugal
|
2006 - 2006 | In vivo/In vitro correlation of intestinal absorption of proteins using animal models and Caco-2 based co-culture cell lines
Supervisor
|
Universidade do Porto, Portugal
|
2006 - 2006 | In vivo/In vitro correlation of intestinal absorption of proteins using animal models and Caco-2 based co-culture cell lines
Supervisor
|
Universidade do Porto, Portugal
|
2006 - 2006 | In vivo/In vitro correlation of intestinal absorption of proteins using animal models and Caco-2 based co-culture cell lines
Supervisor
|
Universidade do Porto, Portugal
|
Event organisation
Event name Type of event (Role) |
Institution / Organization | |
---|---|---|
2021 - 2021 | 2021 Controlled Release Society Annual Meeting (Online), Montreal, Canada, 2021 (2021 - 2021)
Conference (Member of the Organising Committee)
|
Controlled Release Society, United States |
2021 - 2021 | 31st Conference of the European Society of Biomaterials, Porto, Portugal (2021 - 2021)
Congress
|
|
2018 - 2018 | 7th i3S Annual Meeting, Póvoa do Varzim, Portugal, 2018 (2018 - 2018)
Meeting (Member of the Organising Committee)
|
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal |
2017 - 2017 | 6th i3S Annual Meeting, Póvoa do Varzim, Portugal, 2017 (2017 - 2017)
Meeting (Member of the Organising Committee)
|
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal |
2016 - 2016 | XVII Jornadas de Ciências Farmacêuticas do Instituto Universitário de Ciências da Saúde – Marketing Farmacêutica: A Realidade
Portuguesa, Porto, Portugal (2016 - 2016)
Congress (Member of the Organising Committee)
|
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal |
2013 - 2013 | 3rd AAPS-UP Student Chapter Annual Symposium, Porto, Portugal (2013 - 2013)
Symposium (Member of the Organising Committee)
|
Universidade do Porto, Portugal |
2011 - 2011 | XII Jornadas de Ciências Farmacêuticas do Instituto Superior de Ciências da Saúde - Norte - Desafios Futuros das Ciências
Farmacêuticas, Porto, Portugal (2011 - 2011)
Conference (Member of the Organising Committee)
|
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal |
2010 - 2010 | XVIII International Workshop on Bioencapsulation, Porto, Portugal (2011 - 2011)
Workshop (Member of the Organising Committee)
|
|
2010 - 2010 | 70th International Congress of International Pharmaceutics Federation (FIP), Lisbon, Portugal (2010 - 2010)
Congress (Member of the Organising Committee)
|
|
2009 - 2009 | 69th International Congress of International Pharmaceutics Federation (FIP), Istanbul, Turkey (2009 - 2009)
Congress (Member of the Organising Committee)
|
|
2008 - 2008 | 69th International Congress of International Pharmaceutics Federation (FIP), Istanbul, Turkey, 2009 (2008 - 2008)
Congress (Member of the Organising Committee)
|
|
2007 - 2007 | 67th International Congress of International Pharmaceutics Federation (FIP), Beijing, China (2007 - 2007)
Congress (Member of the Organising Committee)
|
|
2007 - 2007 | Pharmaceutical Sciences World Congress (PSWC2007), Amsterdam, Netherland (2007 - 2007)
Congress (Member of the Organising Committee)
|
|
2006 - 2006 | 66th International Congress of FIP, Salvador da Bahia, Brazil (2006 - 2006)
Congress (Member of the Organising Committee)
|
|
2002 - 2002 | V Pharmaceutical Forum “Think teaching, project the future” (2002 - 2002)
Other (Member of the Organising Committee)
|
Event participation
Activity description Type of event |
Event name Institution / Organization |
|
---|---|---|
2023 - Current | Innovative technologies in pharmaceutics and biopharmaceuticals – The exploitation of new routes for old drugs
Seminar
|
13th Congress of the Pharmaceutical Students of Valencia University |
2022 - Current | Nanomedicines for local and intracellular gastrointestinal tumour modulation
Seminar
|
Academia de Ciências Farmacêuticas do Brasil |
2022 - Current | Nanomedicines for local and intracellular gastrointestinal tumour modulation
Seminar
|
Post-graduate Pharmaceutical Sciences Seminary |
2022 - Current | Nanomedicines for local and intracellular gastrointestinal tumour modulation
Seminar
|
King’s College London Institute of Pharmaceutical Science Seminar Series |
Jury of academic degree
Topic Role |
Candidate name (Type of degree) Institution / Organization |
|
---|---|---|
2023/10 | Design of novel protein fibrils-based biomaterials for the regeneration of injured myocardium tissue
(Thesis) Main arguer
|
Tiago Filipe Cruz Carvalho (PhD)
Universidade de Aveiro, Portugal
|
2023/10 | Precision nanotechnology-based therapeutic approaches to enhance tumor-immune cells crosstalk within melanoma stromal microenvironment
(Thesis) Main arguer
|
Ana Bárbara de Sousa Carreira (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2023/09 | Gene therapy mediated by glycopolymers-based nanocarriers in combination with chemotherapeutic drugs as a potential therapeutic
strategy for hepatocellular carcinoma
(Thesis) Main arguer
|
Daniela Filipa Domingues Santo (PhD)
Universidade de Coimbra Departamento de Ciências da Vida, Portugal
|
2023 | Multi-targeted docetaxel polymeric nanoparticles as delivery systems for chemotherapy to treat glioblastoma
Supervisor
|
Claúdia Martins (PhD)
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2023 | Peptide functionalized polymeric nanocarriers: Towards selective targeting of prostate cancer
(Thesis) Arguer
|
Madhura Murar (PhD)
Universitat Autònoma de Barcelona Facultat de Ciències, Spain
|
2022 | Targeted nanomedicines to stimulate the differentiation of oligodendrocyte progenitor cells in the scope of multiple sclerosis
(Thesis) Main arguer
|
Yasmine Labrak (PhD)
Université catholique de Louvain, Belgium
|
2022 | Therapeutic potential of zein-based nanoparticles
(Thesis) Arguer
|
Cristian Reboredo Fuentes (PhD)
Universidad de Navarra, Spain
|
2022 | Hybrid nanoparticles as multifunctional platform for brain tumor therapy
(Thesis) Arguer
|
Maria Manuel Feliciano da Costa Mendes (PhD)
Universidade de Coimbra, Portugal
|
2022 | Exploring the impact of mutant KRAS on epithelial-fibroblasts interactions during colorectal cancer initiation and progression
Thesis Member
|
Patrícia Dias Carvalho (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2022 | Evaluation of lipid nanocapsules for oral absorption using quantitative FRET technology
(Thesis) Arguer
|
Norraseth Kaeokhamloed (PhD) |
2022 | Advanced systems for skin delivery of cyanocobalamin: A model molecule for > 1 kDa drugs
(Thesis) Arguer
|
Antonio José Guillot García (PhD)
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2022 | Impacto do furoato de mometasona sobre a homeostase glicêmica e lipídica: busca por um glicocorticoide com menos efeitos adversos
Supervisor
|
Priscila Zimath (PhD) |
2022 | Targeted nanomedicines to stimulate the differentiation of oligodendrocyte progenitor cells in the scope of multiple sclerosis
(Thesis) Arguer
|
Yasmine Labrak (PhD)
Université catholique de Louvain Louvain Drug Research Institute, Belgium
|
2022 | Prevention of breast cancer brain metastases by minocycline-loaded liposomes | Daniela Alexandra Simão Vaz (Master)
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
2022 | Preserving the blood-brain barrier: a way of preventing breast cancer brain metastases
(Thesis) Main arguer
|
Rafaela Flauzino Silvestre (Master) |
2022 | Dissolution test elimination assessment
(Thesis) Arguer
|
Tania Sofia Rodrigues Freire (Master) |
2021 | Novel chitosan-based Pickering emulsions as green encapsulation systems and delivery vehicles of bioactive agents
(Thesis) Arguer
|
Asma Mohamad Abdallah Sharkawy (PhD)
Universidade do Porto Faculdade de Engenharia, Portugal
|
2021 | New three-dimensional intestinal tissue engineering model as multifunctional platform for drug and nanoparticle absorption
studies
(Thesis) Arguer
|
Maria Helena Rodrigues Macedo (PhD) |
2021 | Mucoadhesive camptothecin polymeric micelles as nanodelivery systems for oral chemotherapy to treat colorectal cancer
(Thesis) Arguer
|
Andreia Marina de Sousa Almeida (PhD) |
2021 | Development of a resveratrol drug delivery system presenting enhanced bioavailability
(Thesis) Arguer
|
Teófilo Cardoso Vasconcelos (PhD) |
2021 | New engineered FcRn-targeting nanoplatfoms for oral delivery of biopharmaceuticals
Supervisor
|
Claudia FIlipa Maia Azevedo (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2021 | Nanotechnology-mediated stratergies targeting cancer stem cells for advanced cancer treatment
(Thesis) Arguer
|
Sara Montero Martin (PhD)
Universitat de Barcelona, Spain
|
2021 | Development of liposomal formulations for therapeutic applications
(Thesis) Arguer
|
Diana Isabel Pereira Guimarães (PhD)
Universidade do Minho, Portugal
|
2021 | The role of NMR spectroscopy in the rationalization of materials properties
(Thesis) Arguer
|
Andrea Cesari (PhD)
Università degli Studi di Pisa, Italy
|
2021 | Dual-purpose oromucosal films and tablets for the local management of oral mucositis
(Thesis) Arguer
|
João Costa Campos (PhD)
Universidade do Porto, Portugal
|
2021 | Evaluation of high-pressure as a novel non-thermal extraction technology to obtain extracts with improved biological activities
(Thesis) Arguer
|
Sílvia Alexandra Monteiro Moreira (PhD) |
2021 | Dissolution test elimination assessment
(Thesis) Main arguer
|
Tania Sofia Rodrigues Freira (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2020 | Dual-purpose oromucosal films and tablets for the local management of oral mucositis
(Thesis) Arguer
|
João Costa Campos (PhD)
Universidade do Porto, Portugal
|
2020 | Bacterial cellulose wound dressing
(Thesis) Arguer
|
Ana Cristina da Costa Rodrigues (PhD)
Universidade do Minho, Portugal
|
2020 | Evaluation of high-pressure as a novel non-thermal extraction technology to obtain extracts with improved biological activities
(Thesis) Arguer
|
Sílvia Alexandra Monteiro Moreira (PhD)
Universidade de Aveiro, Portugal
|
2020 | Theranostic Nanocomposites for Cancer Immunotherapy
(Thesis) Arguer
|
Tomás Bauleth Quinta Ferreira Ramos (PhD)
Universidade do Porto, Portugal
|
2020 | Characterization of nutritional and healthy properties of local Tuscany varieties and evaluation of innovative nanosystems
for the delivery of their nutraceutical components to the human body
(Thesis) Arguer
|
Denise Benconcini (PhD)
Università degli Studi di Siena, Italy
|
2020 | Bacterial cellulose wound dressing
(Thesis) Arguer
|
Ana Cristina da Costa Rodrigues (PhD)
Universidade do Minho, Portugal
|
2019/03/29 | Nanoparticulas poliméricas para vehicular activos farmacéuticos al sistema nervioso central
(Thesis) Main arguer
|
Maria Dolores Cayero Otero (PhD)
University of Sevilla, Faculty of Pharmacy, Spain
|
2019 | Hidrogeles bioactivos para la regeneración óssea em osteoporosis
(Thesis) Arguer
|
Elisabeth Segredo Morales (PhD)
Universidad de La Laguna, Spain
|
2019 | Production and characterization of electrospun membranes for wound dressing applications
(Thesis) Arguer
|
Sónia Alexandra Pereira Miguel (PhD) |
2019 | Bioinspired three-dimensional multifunctional systems to enhance the therapeutic potential of mesenchymal stromal cells
(Thesis) Arguer
|
Ainhoa Gonzalez Pujana (PhD) |
2019 | Libertação controlada de bioativos suportados por nanoparticulas de pseudoboemita obtidas pelo processo sol-gel
(Thesis) Arguer
|
Isabella Tereza Ferro Barbosa (PhD) |
2019 | Development of antihelmintic and antibiotic microneedle delivery systems for treatment of lymphatic filariasis
(Thesis) Arguer
|
Andi Dian Permana (PhD) |
2018 | Development of micro and nanosystems for the treatment of cutaneous leishmaniosis
(Thesis) Arguer
|
Ana Paula dos Santos Matos (PhD) |
2018 | Chitosan in textiles: Towards a greener and functional solution
(Thesis) Arguer
|
Eduardo Manuel Aguiar da Costa (PhD)
Universidade Católica Portuguesa, Portugal
|
2018 | Design and characterization of lipid nanoparticles for an effective topical administration of active compunds
(Thesis) Arguer
|
Fátima Cristina Romão Vieira Pinto (PhD)
Universidade de Lisboa Instituto Superior Técnico, Portugal
|
2018 | Targeting of human CD44v6 with engineered nanoparticles for gastrointestinal cancer diagnosis and therapy
(Thesis) Arguer
|
Patrick Joseph Kennedy (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2018 | Development of PEGylated platforms to overcome blood–brain barrier constraints in neurodegenerative therapy
(Thesis) Arguer
|
Carlos Eduardo Vinhas Fernandes (PhD)
Universidade do Porto Faculdade de Farmácia, Portugal
|
2018 | New prevention and treatment strategies for HIV infection
(Thesis) Arguer
|
Ana Rita Ramos Diniz de Quadros e Costa (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2018 | Multicomponent particulates for immune modulation
(Thesis) Arguer
|
João Miguel de Oliveira Conniot (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2018 | Hybrid lipid-polymeric nanoplatforms as cancer imunotherapeutics
(Thesis) Arguer
|
Vanessa Gameiro Sain (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2018 | Skin delivery of bioactive plant extracts through nanocarriers
Thesis Member
|
Ana Luísa Vargas Henriques Mota (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2018 | Development of curcumin lipid formulations for food applications: transport, permeability and safety evaluation on a mucus-secreting
intestinal epithelial cell model
(Thesis) Arguer
|
João Paulo Caseiro Baixinh (Master)
Universidade Nova de Lisboa, Portugal
|
2018 | Development of Nanoparticle-in-Microparticle systems for oral delivery of triptorelin
(Thesis) Arguer
|
Ana Rita Ribeiro (Master)
Universidade do Porto Faculdade de Engenharia, Portugal
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal |
2017 | Oral immunotherapy based on mucus-penetrating nanoparticles against peanut allergy
(Thesis) Arguer
|
Ana Brotons Cantó (PhD)
Universidad de Navarra Facultad de Farmacia, Spain
|
2017 | Amphiphilic derivatives of chitosan in encapsulation and controlled release of antitumor drug
(Thesis) Arguer
|
Daniella de Souza e Silva (PhD)
Universidade de São Paulo Instituto de Química de São Carlos, Brazil
|
2017 | Advances in graphene-based materials and their composites with focus on biomedical applications
(Thesis) Arguer
|
Artur Daniel Moreira Pint (PhD)
Universidade do Porto Faculdade de Engenharia, Portugal
|
2017 | GLP-1 and GLP-1 analogs nanotechnology-based systems for prevention and therapy of diabetes
(Thesis) Arguer
|
Ana Francisca Lopes Correia de Araúj (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2017 | Modulation of Drug Efflux at the Blood-Brain Barrier through Targeted siRNA Delivery via Nanoparticles
(Thesis) Arguer
|
Maria João Bidarra Tavares Gomes (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2017 | Development of controlled release formulation of high permeability drugs in colon
(Thesis) Arguer
|
Isabel Lozoya Agulló (PhD)
Universidad Miguel Hernández de Elche, Spain
|
2017 | Brain-like endothelial cells derived from stem cells to study blood brain barrier development and targeting
(Thesis) Arguer
|
Catarina Oliveira Praça de Almeida (PhD)
Universidade de Coimbra Instituto de Investigação Interdisciplinar, Portugal
|
2017 | Micro/Nanoparticulas mucoadesivas de goma gelana e pectina para a libertação colon-específica de resveratrol
(Thesis) Arguer
|
Fabíola Garavello Prezotti (PhD)
Universidade Estadual Paulista Júlio de Mesquita Filho - Câmpus de Araraquara, Brazil
|
2017 | Carcinoembryonic antigen targeted polymeric nanoparticles for drug delivery
(Thesis) Arguer
|
Inês Pereira (Master)
Universidade do Porto Faculdade de Engenharia, Portugal
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal |
2017 | Physical supports for immobilization of drug particles or controlled drug delivery systems by bioinspired pollination
(Thesis) Arguer
|
Lúcia Isabel Ferreira Santos (Master)
Universidade de Aveiro, Portugal
|
2017 | Development of polymeric nanoparticles of saquinavir targeting SNC through microfluidic platforms
(Thesis) Arguer
|
Claudia Martin (Master)
Universidade do Porto Faculdade de Engenharia, Portugal
|
2016 | Anti-tumor immunity induced by a novel nanoparticulate vaccine: a mechanistic approac
(Thesis) Arguer
|
Eva Zupancic (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2016 | New derivatives of Locust Bean Gum for application in nanoparticle drug delivery systems
(Thesis) Arguer
|
Luís Manuel Lima Verde de Braz (PhD)
Universidade do Porto Faculdade de Farmácia, Portugal
|
2016 | Protamine nanocapsules as carriers for oral peptide delivery
(Thesis) Arguer
|
Lungile Nomcebo Thwala (PhD)
Universidade de Santiago de Compostela, Spain
|
2016 | Innovative functional polymer therapeutic nanotechnologies for siRNA delivery in lung cancer
(Thesis) Arguer
|
Ana Vanessa Hortas do Nascimento (PhD)
Universidade do Porto Faculdade de Farmácia, Portugal
|
2016 | Novel particulate BCG-loaded delivery system for mucosal immunization against tuberculosis
(Thesis) Arguer
|
Liliana Aranha Caetano (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2016 | Optimization of lyophilization parameters of polymeric nanoparticles for delivery therapeutic proteins
(Thesis) Arguer
|
Pedro Ricardo Martins Lopes da Fonte (PhD)
Universidade do Porto Faculdade de Farmácia, Portugal
|
2016 | Development of monoolein-based lipofection vectors for therapeutic siRNA delivery
(Thesis) Arguer
|
Ana Cristina Norberto Gonçalves de Oliveir (PhD)
Universidade do Minho, Portugal
|
2016 | Desenvolvimento e caracterização de nanopartículas com propriedades mucoadesivas baseadas em ácido hialurônico para liberação
cólon específica de metotrexato
(Thesis) Arguer
|
Fernanda Isadora Boni (Master)
Universidade Estadual Paulista Júlio de Mesquita Filho - Câmpus de Araraquara, Brazil
|
2016 | Development of polycaprolactone-grafted chitosan polymers for mucoadhesive nanodelivery systems
(Thesis) Arguer
|
Andreia Marina de Sousa Almeida (Master)
Universidade do Porto Faculdade de Engenharia, Portugal
|
2016 | Acute and developmental toxicity of gold nanorods on zebrafish (Danio rerio) embryos
(Thesis) Arguer
|
Bárbara Sofia Maia Mesquita (Master)
Universidade do Porto Faculdade de Engenharia, Portugal
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal |
2015 | Development of polymeric nanoparticles containing neuroprotective compounds of Hypericum perforatum
(Thesis) Arguer
|
Ana Isabel de Freitas Tavares de Oliveira (PhD)
Universidade do Minho, Portugal
|
2015 | Protein-based nanodevices for therapeutic applications
(Thesis) Arguer
|
Ana Isabel Sá Loureiro (PhD)
Universidade do Minho, Portugal
|
2015 | Development of nanoparticles containing extracts and/or compounds of medicinal plants (Curcuma longa, Hypericum perforatum
and Withania somniphera) with neuroprotective properties
(Thesis) Arguer
|
Marslin Gregory (PhD)
Universidade do Minho, Portugal
|
2015 | Development and characterization of nano-micro structures as carrier for bioactive compounds
(Thesis) Arguer
|
Karen Stephanse (PhD) |
2015 | Self-assembled polymeric micelles as powders for pulmonary administration of insulin
(Thesis) Arguer
|
Fernanda Raquel da Silva Andrade (PhD)
Universidade do Porto Faculdade de Farmácia, Portugal
|
2015 | Novel particulate antibiotic-loaded platforms as sustained drug delivery systems for bone infection treatment
(Thesis) Arguer
|
Inês da Fonseca Santos Ferreir (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2015 | Functionalized gold nanoparticles as anticancer drug delivery systems
(Thesis) Arguer
|
Daniel Pedro Pires Alves Reis (Master)
Universidade do Porto Faculdade de Engenharia, Portugal
|
2015 | Production of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) containing antitumoral drug (saquinavir)
(Thesis) Arguer
|
Ana Rita dos Santos Azevedo (Master)
Universidade do Porto Faculdade de Engenharia, Portugal
|
2015 | Establishment and optimization of an alginate-anchored tridimensional in vitro intestine model for intestinal absorption purposes
(Thesis) Arguer
|
Sara Isabela Barbosa Carneiro (Master)
Universidade do Porto Faculdade de Engenharia, Portugal
|
2015 | Desenvolvimento de complexos de inclusão bosentana-ciclotextrina e avaliação das características biofarmacêuticas
(Thesis) Arguer
|
Emanuelle Menegazzo Webler (Master)
Universidade Estadual do Oeste do Paraná, Brazil
|
2015 | Desenvolvimento e otimização de peletes de libertação bifásica mediante delineamento experimental
(Thesis) Arguer
|
Sarah Moherdaui Martins (Master)
Universidade Estadual do Oeste do Paraná, Brazil
|
2015 | Modelação multivariada conjugada com espetroscopia NIR para a otimização de uma formulação contendo elevado teor em Vitamina
C
(Thesis) Arguer
|
João Mochão (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2014 | Development of natural-based hydrogel particles using a biomimetic methodology
(Thesis) Arguer
|
Ana Catarina Cardoso Lima (PhD)
Universidade do Minho Centro de Engenharia Biológica, Portugal
|
2014 | Chitosan-based nanomedicine for rosmarinic acid ocular delivery
(Thesis) Arguer
|
Sara Baptista da Silva (PhD)
Universidade do Porto Faculdade de Farmácia, Portugal
|
2014 | Porous silicon-based multicomposites for controlled drug delivery
(Thesis) Arguer
|
Dongfei Liu (PhD)
Helsingin yliopisto Farmaseuttisen kemian osasto, Finland
|
2014 | Application of self-nanoemulsifying drug delivery systems for oral delivery of peptides and proteins, using insulin as a model
protein
(Thesis) Arguer
|
Ping Li (PhD) |
2014 | Experimental and theoretical investigations on the antioxidant behavior of polyphenolics from plants of Western Ghats and
its dyeing properties
Thesis Member
|
Praveena R (PhD)
Adikavi Nannaya University School of Life and Health Sciences, India
|
2014 | Design and fabrication of bio-responsive drug carriers based on protamine and chondroitin sulphat
Thesis Member
|
Krishna Radhakrishna (PhD)
Indian Institute of Science, India
|
2014 | Development and characterization of a co-culture two-dimensional blood brain barrier for study nanoparticle permeation
(Thesis) Arguer
|
Bárbara Bruna da Silva Mendes (Master)
Universidade do Porto Faculdade de Engenharia, Portugal
|
2014 | Development and characterization of three-dimensional intestinal model for studying intestinal nanoparticle absorption
(Thesis) Arguer
|
Carla Luis Ribas Costa Pereira (Master)
Universidade do Porto Faculdade de Engenharia, Portugal
|
2014 | Complex cell-based model of intestine permeabilitY
(Thesis) Arguer
|
Joana Costa (Master)
Universidade do Porto Faculdade de Engenharia, Portugal
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal |
2014 | Lipid-based nanoparticles as innovative systems for improve the oral bioavailability of catechins
(Thesis) Arguer
|
Iuri André Teixeira Frias (Master)
Universidade do Porto Faculdade de Engenharia, Portugal
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal |
2014 | A quality by design approach on pharmaceutical development of orally disintegrating tablet of diazepa
(Thesis) Arguer
|
João Filipe Dias Teixeira (Master)
Universidade de Coimbra, Portugal
|
2014 | Multifunctional solid lipid nanoparticles for theranostics application in rheumatoid arthritis
(Thesis) Arguer
|
João Pedro Albuquerque e Costa (Master)
Universidade do Porto Faculdade de Engenharia, Portugal
|
2013 | Polymeric nanoparticles as carrier systems for antiretroviral agents to be used in the prevention of vaginal HIV transmission
(Thesis) Arguer
|
José Alberto Gonçalves das Neves (PhD)
Universidade do Porto Faculdade de Farmácia, Portugal
|
2013 | Techniques for evaluation of graphene-based materials biocompatibility
Thesis Member
|
Artur Daniel Moreira Pinto (PhD)
Universidade do Porto Faculdade de Engenharia, Portugal
|
2013 | Dissecting the role of spindle assembly checkpoint components in regulating chromosome attachment to the mitotic spindle:
a functional and proteomic-based analysis
Thesis Member
|
Patrícia Manuela Areias da Silva (PhD)
Universidade do Algarve, Portugal
|
2013 | Development and characterization of nanocarrier systems for the delivery of antitubercular drugs
(Thesis) Arguer
|
Ricardo Leandro Delindro Ribeiro (Master)
Universidade do Porto Faculdade de Engenharia, Portugal
|
2013 | Development of multifunctional nanoparticles for targeted therapy and imaging of rheumatoid arthriti
(Thesis) Arguer
|
Catarina da Costa Moura (Master)
Universidade do Porto Faculdade de Engenharia, Portugal
|
2013 | Formulation and characterization of polyphenol loaded nanoparticles: studies on their bioactivity and stability
(Thesis) Arguer
|
Débora Andreia Campelo Campo (Master)
Universidade Católica Portuguesa Instituto de Ciências da Saúde Porto, Portugal
|
2013 | The role of Process Analytical Technology and Quality-by-Design in the context of Dissolution Testing
(Thesis) Arguer
|
Ana Rita Batista Matia (Master)
Universidade do Porto Faculdade de Farmácia, Portugal
|
2013 | Transdermal delivery of pH responsive liposomes containing indomethacin for the treatment of rheumatoid arthritis
Thesis Member
|
Miriam Raquel Fernandes Machado (Master)
Universidade do Porto Faculdade de Engenharia, Portugal
|
2012 | Improvement of in vitro models for drug screening
(Thesis) Arguer
|
Joana Catarina da Rocha Lamego (PhD)
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal
|
2012 | Drug delivery across blood-brain barrier by means of intravenous administration of lipid nanoparticles
(Thesis) Arguer
|
Susana Amélia Marques Martins (PhD)
Universidade do Porto Faculdade de Farmácia, Portugal
|
2012 | New chemotherapy approaches based on mucus-penetrating nanoparticles as carriers of paclitaxel
Thesis Member
|
Patricia Calleja González (PhD)
Universidad de Navarra Facultad de Farmacia, Spain
|
2012 | Chitosan nanogels as an effective nanocarrier for the treatment of melanoma via the transdermal route
Thesis Member
|
M Sabitha (PhD)
Amrita Institute of Medical Sciences and Research Centre, India
|
2012 | Mannosylated nanoparticles for targeted delivery of amphotericin towards visceral leishmaniasis
(Thesis) Arguer
|
Daniela Filipa dos Santos Barros (Master)
Universidade do Porto Faculdade de Ciências, Portugal
|
2012 | Understanding the mechanisms of protein intestinal permeation by using enterocytes-based in vitro co-culture cells
(Thesis) Arguer
|
Ana Francisca Lopes Correia de Araújo (Master)
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
|
2012 | Mucoadhesive chitosan nanoparticles for daptomycin delivery in ocular treatment of bacterial endophthalmitis- Development,
characterization and in vitro evaluation.
(Thesis) Arguer
|
Nádia Suati Silva (Master)
Universidade Católica Portuguesa Instituto de Ciências da Saúde Porto, Portugal
|
2012 | Otimização do processo de obtenção de nanopartículas de poli(anidrido) revestidas com oligopolissacarídeos contendo complexo
de inclusão paclitavex-HPCD
Thesis Member
|
Amauri Ayres de Campos Antaguera (Other)
Universidade Estadual de Maringá, Brazil
|
2011 | Novel acellular vaccines against brucellosis based on particle immunomodulators
(Thesis) Arguer
|
Raquel Maria da Costa Martins (PhD)
Universidad de Navarra Facultad de Farmacia, Spain
|
2011 | Molecular structural conformations and antioxidant characteristics of certain naturally occurring flavonoid compounds: a quantum
chemical study
Thesis Member
|
K Sadasivam (PhD) |
2011 | Eficiência de biofertilizante - bioprotetor na produtividade e qualidade do melão em Argissolo Vermelho Amarelo no Sudoeste
da Bahia
(Thesis) Arguer
|
Wagner da Silva Oliveira (Master)
Universidade Federal Rural de Pernambuco, Brazil
|
2011 | Nanotecnologia como inovação tecnológica aplicada ao transporte e libertação controlada de fármacos
Thesis Member
|
Vera Alexandra Marques Veloso (Master)
Universidade do Porto Faculdade de Farmácia, Portugal
|
2010 | Nanosystems for the treatment of Diabetes mellitus through transmucosal routes
(Thesis) Arguer
|
Angela Valle Gallego (PhD)
Universidade de Santiago de Compostela, Spain
|
2010 | Optimização da estabilidade de formulações cosméticas contendo filtros solares e vitaminas pelo uso de benzotriazolil dodecil
p-cresol
(Thesis) Arguer
|
Vitor Cellia Seixas (Master)
Universidade do Porto Faculdade de Farmácia, Portugal
|
2010 | A Process Analytical Technology Approach based on Spectroscopy Techniques and Multivariate Data Analysis: Quantifying Ternary
Mixtures of Amlodipine Besilate Solid Forms
(Thesis) Arguer
|
Ana Filipa Fontelonga Lemo (Master)
Universidade do Porto Faculdade de Farmácia, Portugal
|
2009 | Preparação e caracterização de dispersões sólidas e micropartículas lipídicas contendo ibuprofeno
(Thesis) Arguer
|
Hugo Emanuel Pereira Pinto de Jesus Almeid (Master)
Universidade do Porto Faculdade de Farmácia, Portugal
|
2008 | Development of alternative micro and nanoparticulate polymeric systems for mucosal delivery of Streptococcus equi antigens
(Thesis) Arguer
|
Helena Isabel Fialho Florindo (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
Association member
Society Organization name | Role | |
---|---|---|
2008 - Current | European Foundation of the Study of Diabetes | Member |
2008 - Current | Bioencapsulation Research Group | |
2008 - Current | Ordem dos Farmacêuticos de Portugal | |
2008 - Current | Sociedade Portuguesa de Ciências Farmacêuticas | |
2008 - Current | Sociedade Portuguesa de Diabetologia | |
2008 - Current | Portuguese Society of Animal Laboratory Sciences | |
2008 - Current | European Foundation for Clinical Nanomedicine - CLINAM | |
2008 - Current | Controlled Release Society | |
2008 - 2018 | European Federation of Pharmaceutical Sciences | Membro |
2015 - 2017 | European Chitin Society | Board Member |
Conference scientific committee
Conference name | Conference host | |
---|---|---|
2012 - Current | 6th Iberoamerican Chitin Symposium / 12th International Conference on Chitin and Chitosan | |
2018 - 2018 | Controlled Release Society Annual Meeting, New York, USA | Controlled Release Society |
2017 - 2017 | XXV International Conference on Bioencapsulation, Nantes, France | |
2016 - 2016 | XXIV International Conference on Bioencapsulation, Lisbon, Portugal | |
2014 - 2014 | International Society of Biomedical Polymers and Polymeric Materials Annual Meeting, Washington, USA | |
2013 - 2013 | 11th International Conference of the European Chitin Society, Porto, Portugal | |
2012 - 2012 | 2nd World Congress on Pharmaceutics and Novel Drug Delivery Systems, San Francisco, USA | |
2011 - 2011 | 71th FIP International Congress, Hyderabad, India | |
2011 - 2011 | Nano2011.pt, Lisbon, Portugal | |
2009 - 2009 | First Workshop Neoplasias, Gandra, Portugal | |
2008 - 2008 | Ehrlich II – 2nd World Conference on Magic Bullets, Nuremberg, Germany |
Course / Discipline taught
Academic session | Degree Subject (Type) | Institution / Organization | |
---|---|---|---|
2021 - Current | Nanomed Master Program, University of Angers, France | (Master) | |
2021 - Current | Nanomed Master Program, University of Angers, France Pre-clinical validation of nanomedicines for clinical translation | ||
2015 - Current | PhD program in Biological Sciences Applied to Health - Coordinator Laboratorial Rotations - Theory and Practice Advanced Course in Nanotechnology, Drug Delivery and Drug Targeting - Theory and Practice | Ciências Biológicas Aplicadas à Saúde (Doutoramento) | Cooperativa de Ensino Superior Politécnico e Universitário, Portugal |
2011 - Current | Nanosystems for Drug Delivery Course – Polymeric nanoparticles for delivery of therapeutic proteins – Theory | Bioengenharia (Mestrado integrado) | Universidade do Porto Faculdade de Engenharia, Portugal |
2008 - Current | Biotechnology Course - Theory and Practice | Terapias Moleculares (Mestrado integrado) | Cooperativa de Ensino Superior Politécnico e Universitário, Portugal |
2008 - Current | Pharmaceutical Technology Course of Solid Dosage Forms - Theory and Practice | Ciências Farmacêuticas (Mestrado integrado) | Cooperativa de Ensino Superior Politécnico e Universitário, Portugal |
2008 - Current | Medicines Analysis Course - Theory and Practice | Ciências Farmacêuticas (Mestrado integrado) | Cooperativa de Ensino Superior Politécnico e Universitário, Portugal |
2008 - Current | Regulatory Course - Theory | Tecnologia Farmacêutica (Mestrado) | Universidade do Porto Faculdade de Farmácia, Portugal |
2019 - 2019 | Seminar: Functionalized nanomedicines for mucosal and cell-driven recognition drug delivery | (Doctor of Philosophy) | Sichuan University West China School of Pharmacy, China |
2018 - 2018 | Seminar: The balance between mucoadhesion and mucodiffusion of nanoparticles to foster mucosal drug delivery | ||
2017 - 2017 | Seminar: Bioengineered nanomedicines for the delivery of anticancer drugs in the gastrointestinal tract | (Postgraduate Certificate) | |
2017 - 2017 | Seminar: Carrying the right drugs to the right place: nanomedicines break down barriers for translational drug-delivery | (Doutoramento) | |
2017 - 2017 | Seminar: Formulation challenges of biopharmaceuticals using engineered nanosystems | (Doutoramento) | |
2015 - 2017 | Pharmaceutical technology applied to new drug products, Theory | Pos (Postgraduate Certificate) | Universidade Estadual do Oeste do Paraná, Brazil |
2015 - 2017 | Bionanomaterials and interfaces at biological systems, Theory | (Postgraduate Certificate) | Universidade Estadual do Oeste do Paraná, Brazil |
2016 - 2016 | Carrying the right drugs to the right place: nanomedicines break down barriers for translational drug delivery to meet our (pre)clinical research needs | (Outros) | |
2016 - 2016 | Seminar: Bioengineering nanomedicines for modulation of mucosal drug delivery | (Postgraduate Certificate) | |
2016 - 2016 | Seminar: Bioengineering nanomedicines for unmet targeted drug delivery | (Postgraduate Certificate) | |
2016 - 2016 | Seminar: Overcoming mucosal barriers for advanced protein delivery, School of Pharmaceutical Sciences | ||
2016 - 2016 | Seminar: Overcoming mucosal barriers for advanced protein delivery, Course Advanced Drug Delivery | (Doutoramento) | |
2016 - 2016 | Seminar: Engineering Towards Health - Bioengineered nanomedicines for unmet targeted drug delivery | ||
2016 - 2016 | Seminar: Bioengineered nanomedicines for unmet targeted drug delivery | ||
2008 - 2016 | Molecular Therapy Course - Theory and Practice | Ciências Farmacêuticas (Mestrado integrado) | Cooperativa de Ensino Superior Politécnico e Universitário, Portugal |
2015 - 2015 | Nanotecnologia aplicada às Ciências Farmacêuticas | (Mestrado) | Universidade Estadual do Oeste do Paraná, Brazil |
2015 - 2015 | Nanotecnologia farmacêutica aplicada à formulação de novos medicamentos | Mestrado em aconselhamento e Informação em Farmácia (Mestrado) | Instituto Politécnico do Porto, Portugal |
2015 - 2015 | Biopolímeros e Sistemas Nanoestruturados: Produção, Caracterização e Aplicações em Fármacos de Origem Biológica | (Outros) | Universidade Presbiteriana Mackenzie, Brazil |
2015 - 2015 | Seminar: Chitosan-functionalized nanomedicines for engineered diabetes and cancer treatment | (Postgraduate Certificate) | |
2015 - 2015 | Seminar: Nanomedicines for modulating diabetes and cancer: Nanoscale tools against Macroscale diseases | (Postgraduate Certificate) | |
2015 - 2015 | Seminar: Nanomedicines for modulating emergent diseases | (Postgraduate Certificate) | |
2015 - 2015 | Seminar: Nanomedicines for improving the efficacy of good drugs into outstanding products: Nanoscale tools against Macroscale diseases | ||
2015 - 2015 | Seminar: Nanomedicines for modulating diabetes – Towards no-invasive administration of antidiabetic peptides | ||
2015 - 2015 | Seminar: Nanotecnologia no desenvolvimento de novos sistemas terapêuticos | ||
2015 - 2015 | Seminar: Nanomedicines for modulating diabetes – Towards invasive administration of antidiabetic peptides | (Doutoramento) | |
2015 - 2015 | Seminar: Nanomedicines for modulating diabetes – Towards invasive administration of antidiabetic peptides | ||
2015 - 2015 | Seminar: Polymeric nanoparticles for drug delivery applications: methods and polymers | ||
2015 - 2015 | Seminar: Nanomedicines for modulating diabetes – Towards no-invasive administration of antidiabetic peptides | ||
2015 - 2015 | A new three-dimensional cell-based intestinal engineered model to explore absorption at earlier stage of drug delivery | ||
2015 - 2015 | Seminar: Improving the efficacy of good drugs into outstanding products - Nanomedicines for exceptional drug bioavailability and target | (Mestrado) | |
2014 - 2015 | Pharmaceutical Technology Course of Liquid and Semi-solid Dosage Forms - Theory and Practice | Ciências Farmacêuticas (Mestrado integrado) | Cooperativa de Ensino Superior Politécnico e Universitário, Portugal |
2008 - 2015 | Pharmacy Internalship Course – Supervisor and Jury Committee | Ciências Farmacêuticas (Mestrado integrado) | Cooperativa de Ensino Superior Politécnico e Universitário, Portugal |
2014 - 2014 | Seminar: Biopolímero e sistemas nanoestruturados: Produção, caracterização e aplicações em fármacos | ||
2014 - 2014 | Seminar: New perspectives on insulin - From molecule to formulation, in New Insights in Diabetes and Obesity | ||
2014 - 2014 | Seminar: Improving the efficacy of good drugs into outstanding products in the R&D Process: Nanomedicines for exceptional drug bioavailability and target | ||
2013 - 2013 | Bionanotechnology applied to Pharmaceutical Sciences | (Outros) | Universidade Estadual do Oeste do Paraná, Brazil |
2013 - 2013 | Biopolymers and nanostructured systems: production, characterization and application for biopharmaceutical drugs | (Outros) | Universidade de São Paulo Instituto de Química de São Carlos, Brazil |
2013 - 2013 | Challenges in formulation and delivery of biopharmaceutical drugs – the insulin case study | ||
2013 - 2013 | In vitro intestinal co-culture cell model to evaluate and correlate in vivo intestinal absorption of proteins and nanoparticles | ||
2013 - 2013 | Seminar: Chitosan-based systems for the delivery of biopharmaceutical drugs | ||
2012/12 - 2012/12 | Bionanotechnology, development of colloidal vectors for administration of biomolecules of biotechnological origin - Theory | (Postgraduate Certificate) | Universidade Estadual de Maringá Centro de Ciências da Saúde, Brazil |
2012 - 2012 | Bionanotechnology, development of colloidal vectors for administration of biomolecules of biotechnological origin | (Outros) | Universidade Estadual de Maringá Centro de Ciências da Saúde, Brazil |
2012 - 2012 | Seminar: Challenges in formulation and delivery of biopharmaceutical drugs | ||
2012 - 2012 | Seminar: In vitro intestinal co-culture cell model to evaluate and correlate in vivo intestinal absorption of chitosan-based mucoadhesive nanoparticles and insulin as model therapeutic protein | ||
2012 - 2012 | Chitosan-based nanoparticles for the oral absorption enhancement of insulin - Theoretical concepts and fundamental case studies | ||
2012 - 2012 | Chitosan-based nanoparticles for the oral absorption enhancement of insulin - Theoretical concepts and fundamental case studies | ||
2010 - 2012 | Gene therapy Course - Theory | Terapias Moleculares (Mestrado integrado) | Cooperativa de Ensino Superior Politécnico e Universitário, Portugal |
2011 - 2011 | Pharmaceutical Technology Course of Solid Dosage Forms – Theory | (Mestrado integrado) | Universidade da Beira Interior Faculdade de Ciências da Saúde, Portugal |
2011 - 2011 | Pharmaceutical Technology Course of New Drug Delivery Systems – Theory | (Mestrado integrado) | Universidade da Beira Interior Faculdade de Ciências da Saúde, Portugal |
2011 - 2011 | Seminar: A nanotecnologia como estratégia de aumento da biodisponibilidade intestinal de insulina | ||
2011 - 2011 | Seminar: Oral insulin delivery: Current status and our contribution by encapsulating insulin into chitosan-coated lipid nanoparticles | ||
2011 - 2011 | Seminar: Chitosan-coated solid lipid nanoparticles for the oral absorption enhancement of insulin | ||
2010 - 2011 | Biotechnology Course - Theory and Practice | Tecnologia Farmacêutica (Mestrado integrado) | Universidade do Porto Faculdade de Farmácia, Portugal |
2010/06 - 2010/06 | Nanomedicines and delivery of biopharmaceutics – Theory | (Master) | Institut d'Investigacions Biomèdiques de Barcelona, Spain |
2010 - 2010 | Nanotechnology, Drug Delivery and Drug Targeting Course State of the art of Nanotechnology for Drug Delivery Applications – Theory Polymeric Nanoparticles and Targeted Nanosystems – Theory | Ciências Farmacêuticas (Doutoramento) | Universidade do Porto Faculdade de Farmácia, Portugal |
2010 - 2010 | Nanotechnology, Drug Delivery and Drug Targeting Course | (Doutoramento) | Universidade do Porto Faculdade de Farmácia, Portugal |
2010 - 2010 | Seminar: Chitosan-based nanoparticles for delivery of therapeutic proteins | ||
2010 - 2010 | Seminar: Use of Nanotechnology for Delivery of Essential Oils and Other Natural Compounds with Therapeutic Applications | ||
2010 - 2010 | Seminar: Nanomedicines to improve bioavailability of biopharmaceuticals, CICS seminary series | ||
2008 - 2010 | Liquid Dosage Forms Course - Theory and Practice | Tecnologia Farmacêutica (Mestrado) | Universidade do Porto Faculdade de Farmácia, Portugal |
2008 - 2010 | Nanotechnology Course - Nanoencapsulation of Therapeutic Proteins – Theory | (Mestrado) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2009 - 2009 | Seminar: Oral delivery of therapeutic proteins: How far we are? | ||
2009 - 2009 | Seminar: The role of nanotechnologies, New manipulated medicines and new therapeutic systems | ||
2009 - 2009 | Seminar: Nanomedicines for Delivery of Biopharmaceutics | ||
2009 - 2009 | Seminar: Chitosan-based nanomedicines for delivery of biopharmaceutics | ||
2008/03 - 2008/07 | Pharmaceutical Technology Course of Liquid Dosage Forms - Theory and Practice | Ciências Farmacêuticas (Mestrado integrado) | Cooperativa de Ensino Superior Politécnico e Universitário, Portugal |
2008 - 2008 | Pharmaceutical Technology Course of Solid Dosage Forms – Theory | (Mestrado integrado) | Universidade do Algarve Escola Superior de Saúde, Portugal |
2008 - 2008 | Seminar: Chitosan-stealth polymeric nanoparticles for intestinal insulin delivery |
Evaluation committee
Activity description Role |
Institution / Organization | Funding entity | |
---|---|---|---|
2017 - Current | Grant Reviewer
Evaluator
|
Grantová agentura Ceské republiky, Czech Republic | |
2016 - Current | Grant Reviewer
Evaluator
|
||
2016 - Current | Grant Reviewer
Evaluator
|
Agencia Nacional De Promoción Científica Y Tecnológica, Argentina | |
2016 - Current | Grant Reviewer
Evaluator
|
American Diabetes Association Research Foundation, United States | |
2016 - Current | Grant Reviewer
Evaluator
|
American Association of Pharmaceutical Scientists, United States | |
2016 - Current | Grant Reviewer
Evaluator
|
Fonds zur Förderung der wissenschaftlichen Forschung, Austria | |
2016 - Current | Grant Reviewer
Evaluator
|
Conselho Nacional de Desenvolvimento Científico e Tecnológico, Brazil | |
2016 - Current | Grant Reviewer
Evaluator
|
Diabetes UK, United Kingdom | |
2016 - Current | Grant Reviewer
Evaluator
|
Nederlandse Biotechnologische Vereniging, Netherlands | |
2016 - Current | Grant Reviewer
Evaluator
|
Eesti Teadusagentuur, Estonia | |
2016 - Current | Grant Reviewer - European Comission, Horizon2020 Projects
Evaluator
|
||
2016 - Current | Grant Reviewer
Evaluator
|
Fonds de la Recherche Scientific, Belgium | |
2016 - Current | Grant Reviewer
Evaluator
|
Agence nationale de la recherche, France | |
2016 - Current | Grant Reviewer
Evaluator
|
Fundação para a Ciência e a Tecnologia, Portugal | |
2016 - Current | Grant Reviewer
Evaluator
|
Bundesministerium der Verteidigung, Germany | |
2016 - Current | Grant Reviewer
Evaluator
|
Université de Bordeaux, France | |
2016 - Current | Grant Reviewer
Evaluator
|
International Pharmaceutical Federation, Netherlands | |
2016 - Current | Grant Reviewer - Italian Ministry for Education, University and Research
Evaluator
|
||
2016 - Current | Grant Reviewer
Evaluator
|
Israel Science Foundation, Israel | |
2016 - Current | Grant Reviewer - Israeli ministry of Science, Technology and Space
Evaluator
|
||
2016 - Current | Grant Reviewer
Evaluator
|
Katholieke Universiteit Leuven Onderzoeksraad, Belgium | |
2016 - Current | Grant Reviewer
Evaluator
|
Narodowe Centrum Badan i Rozwoju, Poland | |
2016 - Current | Grant Reviewer
Evaluator
|
National Marine Fisheries Service, United States | |
2016 - Current | Grant Reviewer
Evaluator
|
National Medical Research Council, Singapore | |
2016 - Current | Grant Reviewer - National Science Center, Poland
Evaluator
|
||
2016 - Current | Grant Reviewer
Evaluator
|
Fonds Wetenschappelijk Onderzoek Vlaanderen, Belgium | |
2016 - Current | Grant Reviewer - Romanian Government through the National Research Council (CNCS), Romania
Evaluator
|
||
2016 - Current | Grant Reviewer
Evaluator
|
Sankt-Peterburgskij gosudarstvennyj pediatriceskij medicinskij universitet, Russia | |
2016 - Current | Grant Reviewer
Evaluator
|
Schweizerischer Nationalfonds zur Förderung der wissenschaftlichen Forschung, Switzerland | |
2016 - Current | Grant Reviewer - The Welcome trust/DBT India Alliance, UK
Evaluator
|
||
2016 - Current | Grant Reviewer
Evaluator
|
Humane Research Trust, United Kingdom | |
2016 - Current | Grant Reviewer - Versus Arthritis
Evaluator
|
||
2016 - Current | Grant Reviewer
Evaluator
|
William Harvey Research Institute, United Kingdom |
Interview (newspaper / magazine)
Activity description | Newspaper / Forum | |
---|---|---|
2018 | Pessoas da UP | UP Newsletter |
2018 | No topo da nanomedicina | Jornal de Notícias |
2018 | Cafein films | Diário de Notícias |
2017 | 62 papers | Público |
2016 | Filme HIV | Público |
Interview (tv / radio show)
Program | Topic | |
---|---|---|
2018 - Current | Olhar o Mundo | |
2017 - Current | 90 segundos de ciência | |
2015 - Current | Mentes que brilham |
Journal scientific committee
Journal title (ISSN) | Publisher | |
---|---|---|
2018 - Current | Journal of Controlled Release (0168-3659) | Elsevier |
2017 - Current | European Journal of Pharmaceutical Sciences (0928-0987) | Elsevier |
2016 - Current | Expert Opinion on Drug Delivery (1744-7593) | Informa UK (Taylor & Francis) |
2008 - Current | AAPS PharmSciTech (1530-9932) | American Association of Pharmaceutical Scientists |
2008 - Current | ACS Applied Materials & Interfaces (1944-8252) | American Chemical Society |
2008 - Current | ACS Biomaterials Science & Engineering (2373-9878) | American Chemical Society |
2008 - Current | ACS Nano (1936-086X) | American Chemical Society |
2008 - Current | Acta biomaterialia | |
2008 - Current | Acta Chromatographica (2083-5736) | Akademiai Kiado Zrt. |
2008 - Current | Acta Diabetologica (1432-5233) | Springer-Verlag |
2008 - Current | Acta Pharmaceutica (1846-9558) | De Gruyter Open Sp. z o.o. |
2008 - Current | Advanced Drug Delivery Reviews (0169-409X) | Elsevier |
2008 - Current | Advanced Functional Materials (1616-3028) | Wiley (John Wiley & Sons) |
2008 - Current | Advanced Healthcare Materials (2192-2640) | Wiley (John Wiley & Sons) |
2008 - Current | Advanced Materials (1521-4095) | Wiley (John Wiley & Sons) |
2008 - Current | Advanced Materials Technologies (2365-709X) | Wiley (John Wiley & Sons) |
2008 - Current | Advanced Therapeutics (2366-3987) | Wiley (John Wiley & Sons) |
2008 - Current | AFRICAN JOURNAL OF BIOTECHNOLOGY (1684-5315) | Academic Journals |
2008 - Current | Alternatives to laboratory animals | |
2008 - Current | Anaerobe (1095-8274) | Elsevier |
2008 - Current | Analytical Methods (1759-9679) | The Royal Society of Chemistry |
2008 - Current | Arabian Journal of Chemistry (1878-5352) | Elsevier |
2008 - Current | Ars Pharmaceutica (Internet) (2340-9894) | Instituto de Salud Carlos III/BNCS/SciELO Espana |
2008 - Current | Assay and Drug Development Technologies (1557-8127) | Mary Ann Liebert |
2008 - Current | Basic & Clinical Pharmacology & Toxicology (1742-7843) | Wiley (Blackwell Publishing) |
2008 - Current | Bioconjugate Chemistry (1520-4812) | American Chemical Society |
2008 - Current | BioDrugs (1179-190X) | Springer-Verlag |
2008 - Current | Biomedical Chromatography (1099-0801) | Wiley (John Wiley & Sons) |
2008 - Current | Biomacromolecules (1526-4602) | American Chemical Society |
2008 - Current | Biomaterials (0142-9612) | Elsevier |
2008 - Current | BioMed Research International (2314-6141) | Hindawi Limited |
2008 - Current | Biomedicine & Pharmacotherapy (0753-3322) | Elsevier |
2008 - Current | Bioorganic & Medicinal Chemistry (0968-0896) | Elsevier |
2008 - Current | Biophysical Chemistry (0301-4622) | Elsevier |
2008 - Current | Biotechnology Advances (0734-9750) | Elsevier |
2008 - Current | Biotechnology and Bioengineering (1097-0290) | Wiley (John Wiley & Sons) |
2008 - Current | BMC Complementary and Alternative Medicine (1472-6882) | Springer (Biomed Central Ltd.) |
2008 - Current | British Journal of Cancer (1532-1827) | Springer Nature |
2008 - Current | Cancer Letters (0304-3835) | Elsevier |
2008 - Current | Cancer Research (1538-7445) | American Association for Cancer Research |
2008 - Current | Carbohydrate Polymers (0144-8617) | Elsevier |
2008 - Current | Cell Biochemistry and Biophysics (1559-0283) | Springer-Verlag |
2008 - Current | Biomatter (2159-2535) | Landes Bioscience |
2008 - Current | Carbohydrate Research (0008-6215) | Elsevier |
2008 - Current | Cell Biology International (1095-8355) | Wiley (John Wiley & Sons) |
2008 - Current | Chemical Communications | |
2008 - Current | Chemical Engineering Journal (1385-8947) | Elsevier |
2008 - Current | Chemistry of Materials (1520-5002) | American Chemical Society |
2008 - Current | ChemMedChem (1860-7187) | Wiley (John Wiley & Sons) |
2008 - Current | Chemical Reviews (1520-6890) | American Chemical Society |
2008 - Current | Chemical Science (2041-6539) | The Royal Society of Chemistry |
2008 - Current | Clinical Cosmetic and Investigational Dermatology (1178-7015) | Dove Medical Press |
2008 - Current | Colloids and Surfaces A: Physicochemical and Engineering Aspects | |
2008 - Current | Colloids and Surfaces B: Biointerfaces | |
2008 - Current | Composites Science and Technology (0266-3538) | Elsevier |
2008 - Current | Computer Methods and Programs in Biomedicine | |
2008 - Current | Chronicles of Young Scientists (2229-5186) | Medknow Publications |
2008 - Current | Critical Reviews in Biotechnology (1549-7801) | Informa UK (Taylor & Francis) |
2008 - Current | Current Diabetes Reviews (1573-3998) | Bentham Science |
2008 - Current | Current Drug Delivery | |
2008 - Current | Current Drug Discovery Technologies (1570-1638) | Bentham Science |
2008 - Current | Current Drug Metabolism (1389-2002) | Bentham Science |
2008 - Current | Current Drug Targets (1389-4501) | Bentham Science |
2008 - Current | Current Medicinal Chemistry (0929-8673) | Bentham Science |
2008 - Current | Current Nanomedicine (2468-1873) | Bentham Science |
2008 - Current | Current Nanoscience (1573-4137) | Bentham Science |
2008 - Current | Current Opinion in Colloid & Interface Science (1359-0294) | Elsevier |
2008 - Current | Current Pharmaceutical Biotechnology (1389-2010) | Bentham Science |
2008 - Current | Diabetes/Metabolism Research and Reviews (1520-7560) | Wiley (John Wiley & Sons) |
2008 - Current | Drug Delivery (1521-0464) | Informa UK (Taylor & Francis) |
2008 - Current | Drug Delivery and Translational Research (2190-3948) | Springer-Verlag |
2008 - Current | Drug Delivery Letters (2210-3031) | Bentham Science |
2008 - Current | Drug Development and Industrial Pharmacy (1520-5762) | Informa UK (Taylor & Francis) |
2008 - Current | Drug Design Development and Therapy (1177-8881) | Dove Medical Press |
2008 - Current | Drug Discovery Today (1359-6446) | Elsevier |
2008 - Current | Drying Technology (1532-2300) | Informa UK (Taylor & Francis) |
2008 - Current | European Journal of Lipid Science and Technology (1438-9312) | Wiley (John Wiley & Sons) |
2008 - Current | European Journal of Nanomedicine (1662-596X) | Walter de Gruyter GmbH (European Journal of Nanomedicine) |
2008 - Current | European Journal of Pharmaceutics and Biopharmaceutics (0939-6411) | Elsevier |
2008 - Current | European Journal of Pharmaceutical Sciences (0928-0987) | Elsevier |
2008 - Current | Experimental Dermatology (1600-0625) | Wiley (Blackwell Publishing) |
2008 - Current | Expert Opinion on Drug Delivery (1744-7593) | Informa UK (Taylor & Francis) |
2008 - Current | Expert Opinion on Drug Discovery (1746-045X) | Informa UK (Taylor & Francis) |
2008 - Current | Expert Opinion on Therapeutic Patents (1744-7674) | Informa UK (Taylor & Francis) |
2008 - Current | Expert Review of Endocrinology & Metabolism (1744-8417) | Informa UK (Taylor & Francis) |
2008 - Current | Expert Review of Endocrinology & Metabolism (1744-8417) | Informa UK (Taylor & Francis) |
2008 - Current | Flavour and Fragrance Journal (1099-1026) | Wiley (John Wiley & Sons) |
2008 - Current | Food & Function (2042-650X) | The Royal Society of Chemistry |
2008 - Current | Food Hydrocolloids (0268-005X) | Elsevier |
2008 - Current | Hepatology (1527-3350) | Wiley (John Wiley & Sons) |
2008 - Current | Indian Journal of Pharmaceutical Sciences | |
2008 - Current | International Journal of Antimicrobial Agents (0924-8579) | Elsevier |
2008 - Current | International Journal of Biological Macromolecules (0141-8130) | Elsevier |
2008 - Current | International Journal of Molecular Sciences (1422-0067) | MDPI AG |
2008 - Current | International Journal of Nanomedicine (1178-2013) | Dove Medical Press |
2008 - Current | International Journal of Oncology (1791-2423) | Spandidos Publications |
2008 - Current | International Journal of Pharmaceutics (0378-5173) | Elsevier |
2008 - Current | International Journal of Pharmacy Practice (0961-7671) | Wiley (Blackwell Publishing) |
2008 - Current | Journal of Biomolecular Structure and Dynamics (1538-0254) | Informa UK (Taylor & Francis) |
2008 - Current | Journal of Biomaterials Applications (1530-8022) | SAGE Publications |
2008 - Current | Journal of Biomaterials Science: Polymer Edition | |
2008 - Current | Journal of Biomedical Materials Research: Part A | |
2008 - Current | Journal of Biomedical Materials Research: Part B - Applied Biomaterials | |
2008 - Current | Journal of Biomedical Nanotechnology (1550-7033) | American Scientific Publishers |
2008 - Current | Journal of Nanobiotechnology (1477-3155) | Springer (Biomed Central Ltd.) |
2008 - Current | Journal of Biopharmaceutics and Biotechnology | |
2008 - Current | Journal of the Brazilian Chemical Society (0103-5053) | Sociedade Brasileira de Quimica (SBQ) |
2008 - Current | Journal of Chromatography B (1570-0232) | Elsevier |
2008 - Current | Journal of Colloid and Interface Science (1095-7103) | Elsevier |
2008 - Current | Journal of Colloid Science and Biotechnology | |
2008 - Current | Journal of Controlled Release (0168-3659) | Elsevier |
2008 - Current | Journal of Drug Delivery (2090-3022) | Hindawi Limited |
2008 - Current | Journal of Drug Delivery Science and Technology (1773-2247) | Elsevier |
2008 - Current | Journal of Food Engineering (0260-8774) | Elsevier |
2008 - Current | Journal of Functional Foods (1756-4646) | Elsevier |
2008 - Current | Journal of Herbal Medicine (2210-8033) | Elsevier |
2008 - Current | Journal of Lower Genital Tract Disease (1526-0976) | Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins |
2008 - Current | Journal of Materials Chemistry B (2050-7518) | The Royal Society of Chemistry |
2008 - Current | Journal of the Mechanical Behavior of Biomedical Materials (1751-6161) | Elsevier |
2008 - Current | Journal of Medicinal Food (1557-7600) | Mary Ann Liebert |
2008 - Current | Journal of Membrane Science (0376-7388) | Elsevier |
2008 - Current | Journal of Microencapsulation (1464-5246) | Informa UK (Taylor & Francis) |
2008 - Current | Journal of Nanobiotechnology (1477-3155) | Springer (Biomed Central Ltd.) |
2008 - Current | Journal of Nanoscience and Nanotechnology (1533-4880) | American Scientific Publishers |
2008 - Current | Journal of Neuroimmune Pharmacology (1557-1904) | Springer-Verlag |
2008 - Current | Journal of Pharmaceutical Sciences (1520-6017) | Elsevier |
2008 - Current | Journal of Pharmacological and Toxicological Methods (1056-8719) | Elsevier |
2008 - Current | Journal of Pharmacy And Bioallied Sciences (0975-7406) | Medknow Publications |
2008 - Current | Journal of Pharmacy and Pharmacology (2042-7158) | Wiley (Blackwell Publishing) |
2008 - Current | Journal of Phytopathology (1439-0434) | Wiley (Blackwell Publishing) |
2008 - Current | Journal of Taibah University for Science (1658-3655) | Informa UK (Taylor & Francis) |
2008 - Current | Journal of The Royal Society Interface (1742-5662) | The Royal Society |
2008 - Current | Lab on a Chip (1473-0189) | The Royal Society of Chemistry |
2008 - Current | Langmuir (1520-5827) | American Chemical Society |
2008 - Current | Macromolecular Bioscience (1616-5195) | Wiley (John Wiley & Sons) |
2008 - Current | Macromolecular Rapid Communications (1521-3927) | Wiley (John Wiley & Sons) |
2008 - Current | Macromolecules (1520-5835) | American Chemical Society |
2008 - Current | Malaysian Journal of Medical Sciences (2180-4303) | Penerbit Universiti Sains Malaysia |
2008 - Current | Marine Drugs (1660-3397) | MDPI AG |
2008 - Current | Materials & Design (0264-1275) | Elsevier |
2008 - Current | Materials Science and Engineering C (0928-4931) | Elsevier |
2008 - Current | Medicinal Research Reviews (1098-1128) | Wiley (John Wiley & Sons) |
2008 - Current | Molecular Pharmaceutics (1543-8392) | American Chemical Society |
2008 - Current | Molecular Therapy — Methods & Clinical Development (2329-0501) | Elsevier |
2008 - Current | Molecules (1420-3049) | MDPI AG |
2008 - Current | Nano Letters (1530-6992) | American Chemical Society |
2008 - Current | Nanomedicine (1748-6963) | Future Medicine |
2008 - Current | Nanomedicine: Nanotechnology, Biology, and Medicine | |
2008 - Current | Nanoscale (2040-3372) | The Royal Society of Chemistry |
2008 - Current | Nanotechnology Reviews (2191-9097) | Walter de Gruyter GmbH |
2008 - Current | Nanotoxicology (1743-5404) | Informa UK (Taylor & Francis) |
2008 - Current | Natural Product Research (1029-2349) | Informa UK (Taylor & Francis) |
2008 - Current | Nature Protocols (1754-2189) | Springer Nature |
2008 - Current | Nutrients (2072-6643) | MDPI AG |
2008 - Current | Oncotarget (1949-2553) | "Impact Journals, LLC " |
2008 - Current | Parasitology Research (1432-1955) | Springer-Verlag |
2008 - Current | Particuology (1674-2001) | Elsevier |
2008 - Current | Patent Book Series on Anticancer | |
2008 - Current | Pharmaceutica Analytica Acta (2153-2435) | OMICS Publishing Group |
2008 - Current | Pharmaceutical Development and Technology (1097-9867) | Informa UK (Taylor & Francis) |
2008 - Current | Pharmaceutical Nanotechnology (2211-7385) | Bentham Science |
2008 - Current | Pharmaceutical Research (1573-904X) | Springer-Verlag |
2008 - Current | Pharmaceutics (1999-4923) | MDPI AG |
2008 - Current | Photochemistry and Photobiology (0031-8655) | Wiley (Blackwell Publishing) |
2008 - Current | PlosOne | |
2008 - Current | Polímeros - Ciência e Tecnologia | |
2008 - Current | Polish Journal of Chemical Technology (1899-4741) | De Gruyter Open Sp. z o.o. |
2008 - Current | Polymer Bulletin (1436-2449) | Springer-Verlag |
2008 - Current | Progress in Neurobiology (0301-0082) | Elsevier |
2008 - Current | Progress in Polymer Science (0079-6700) | Elsevier |
2008 - Current | Protein and Peptide Letters (0929-8665) | Bentham Science |
2008 - Current | RCS Advances | |
2008 - Current | Reactive and Functional Polymers (1381-5148) | Elsevier |
2008 - Current | Recent Patents in Drug Delivery and Formulation | |
2008 - Current | Recent Patents on DNA & Gene Sequences (1872-2156) | Bentham Science |
2008 - Current | Recent Patents on Nanomedicine (1877-9123) | Bentham Science |
2008 - Current | Regenerative Medicine | Science Repository OU |
2008 - Current | Revista Colombiana de Biotecnología (1909-8758) | Universidad Nacional de Colombia |
2008 - Current | Saudi Pharmaceutical Journal (1319-0164) | Elsevier |
2008 - Current | Scientific Reports (2045-2322) | Springer Nature |
2008 - Current | Seminars in Immunology (1096-3618) | Elsevier |
2008 - Current | Small | |
2008 - Current | Soft Matter (1744-6848) | The Royal Society of Chemistry |
2008 - Current | The AAPS Journal (1550-7416) | American Association of Pharmaceutical Scientists |
2008 - Current | Therapeutic Delivery (2041-6008) | "Future Science, LTD" |
2008 - Current | Theranostics (1838-7640) | Ivyspring International Publisher |
2008 - Current | Tissue Engineering (1076-3279) | Mary Ann Liebert |
2008 - Current | Tissue Engineering Part C Methods (1937-3392) | Mary Ann Liebert |
2008 - Current | Toxicology Letters (0378-4274) | Elsevier |
2008 - Current | Vaccine (0264-410X) | Elsevier |
2008 - Current | WIREs Nanomedicine & Nanobiotechnology | |
2008 - Current | World Journal of Dermatology (2218-6190) | Baishideng Publishing Group Co (World Journal of Dermatology) |
Distinctions
Award
2021 | College of Fellows
Controlled Release Society, United States
|
2020 | European Space Agency - SpinYourThesis
European Space Agency, France
|
Other distinction
2018 | First place of BIOTECH_agrifood INNOVATION - OraLeaf - Associação de nanopartículas a filmes orais para libertação de compostos bioactivos |
2018 | Best poster presentation, Ana Costa, Cristiane Carvalho-Wodarz, Bruno Sarmento, Claus-Michael Lehr, Vítor Seabra, The use of a three-dimensional in vitro alveolar model to test the translocation of nanocarriers and the proinflammatory response |
2016 | Resolve - Nanoparticles-in-film containing antiretroviral drugs for preventing vaginal HIV transmission |
2015 | Third placed on iUP25k University of Porto Innovation program
Universidade do Porto, Portugal
|
2014 | Best poster presentation, Sandra Soares, Pedro Fonte, Ana Costa, Vitor Seabra, Salette Reis, Bruno Sarmento, A multivariable approach to evaluate freeze-drying, cryoprotectants and storage conditions on the stability of structure of insulin-loaded SLN |
2014 | Second place poster award, José das Neves, Bruno Sarmento, In vivo safety assessment of microbicide nanoparticles intended for the prevention of vaginal HIV transmission |
2013 | Best poster presentation, Catarina Moura, José das Neves, Salette Reis, Bruno Sarmento, Development of multifunctional nanoparticles for targeted imaging and therapy of rheumatoid arthritis, , Fifth Symposium of Bioengineering, Porto, Portugal |
2012 | Most downloaded paper award of Drug Delivery and Translational Research Springer, Pedro Fonte, Tiago Nogueira, Christiane Gehm, Domingos Ferreira, Bruno Sarmento, Chitosan-coated solid lipid nanoparticles enhance the oral absorption of insulin |
2012 | Mejor trabajo en Tecnologia Farmacéutica, Marcela Moretton, Diego Chiappetta, Fernanda Andrade, José das Neves, Domingos Ferreira, Bruno Sarmento, Alejandro Sosnik, Hydrolyzed galactomannan to actively target rifampicin-loaded nanocarriers to macrophages |
2011 | XIX International Conference on Bioencapsulation outstanding contribution, Pedro Fonte, José Andrade, Vítor Seabra, Domingos Ferreira, Bruno Sarmento. “Oral absorption enhancement of insulin-loaded chitosan-coated solid lipid nanoparticles" |
2008 | Galenos Euro-PhD in Advanced Drug Delivery |
2007 | PSWC award
Fondation pour l'Innovation Politique, France
|
2007 | Award Dr. M. M. Almeida Ruas/ Portuguese Society of Diabetology
Sociedade Portuguesa de Diabetologia, Portugal
|
2007 | Best poster presentation of Congresso Nacional dos Farmacêuticos
Ordem dos Farmaceuticos, Portugal
|
2007 | Post-Doc Grant
Fundação para a Ciência e a Tecnologia, Portugal
|
2007 | Best poster presentation of Congresso Nacional dos Farmacêuticos Ordem dos Farmacêuticos, Bruno Sarmento, António Ribeiro, Francisco Veiga, Ronald Neufeld, Lene Jorgensen, Marco Van de Weert, Domingos Ferreira, “Aumento efectivo da biodisponibilidade oral |
2006 | AAPS Pharmaceutical Technologies Section Award |
2006 | VII Spanish-Portuguese Conference on Controlled Drug Delivery Award |
2006 | MOST CITED PAPER AWARD the of Colloids and Surfaces B: Biointerfaces |
2004 | PhD Grant
Fundação para a Ciência e a Tecnologia, Portugal
|